https://curecurrent.com/trials/study-of-ik-595-in-ras-or-raf-altered-advanced-tumors-44863 https://curecurrent.com/trials/the-use-of-molecular-radiogenomics-in-non-small-cell-lung-cancer-44864 https://curecurrent.com/trials/jyp0322-versus-platinum-based-doublet-chemotherapy-in-ros1-positive-patients-previously-treated-with-ros1-tkis-44865 https://curecurrent.com/trials/clinical-effectiveness-assessment-of-veristrat-testing-and-validation-of-immunotherapy-tests-in-nsclc-subjects-44866 https://curecurrent.com/trials/high-dose-firmonertinib-plus-bevacizumab-as-neoadjuvant-therapy-for-resectable-egfrm-stage-ii-iiib-nsclc-44867 https://curecurrent.com/trials/radiograph-accelerated-detection-and-identification-of-cancer-in-the-lung-44868 https://curecurrent.com/trials/sunset-sbrt-for-ultra-central-nsclc-a-safety-and-efficacy-trial-44869 https://curecurrent.com/trials/assessment-of-precision-irradiation-in-early-nsclc-and-interstitial-lung-disease-44870 https://curecurrent.com/trials/a-study-of-bl-m14d1-in-patients-with-locally-advanced-or-metastatic-small-cell-lung-cancer-neuroendocrine-tumors-and-oth-44871 https://curecurrent.com/trials/liquid-biopsy-to-predict-responses-to-first-line-immunotherapy-in-metastatic-non-small-cell-lung-cancer-liberty-lung-44872 https://curecurrent.com/trials/cobimetinib-in-refractory-langerhans-cell-histiocytosis-lch-and-other-histiocytic-disorders-44873 https://curecurrent.com/trials/the-lungvision-navigational-platform-for-preoperative-labeling-of-pulmonary-ground-glass-nodules-with-fiducial-markers-44874 https://curecurrent.com/trials/assessing-the-efficacy-and-safety-of-selective-metabolically-adaptive-radiation-dose-escalation-in-locally-advanced-non-44875 https://curecurrent.com/trials/a-study-of-pf-07820435-as-a-single-agent-and-in-combination-in-participants-with-advanced-solid-tumors-44876 https://curecurrent.com/trials/oncosweep-cancer-spotlight-and-spectrum-product-line-44877 https://curecurrent.com/trials/analysis-of-deoxyribonucleic-acid-and-ribonucleic-acid-next-generation-sequencing-in-non-small-cell-lung-cancer-patients-44878 https://curecurrent.com/trials/pembrolizumab-versus-chemotherapy-and-pembrolizumab-in-non-small-cell-lung-cancers-nsclc-with-pdl1-50-44879 https://curecurrent.com/trials/monarch-robotic-bronchoscopy-for-lung-nodule-icg-dye-marking-before-vats-44880 https://curecurrent.com/trials/needle-based-confocal-laser-endomicroscopy-for-diagnosis-of-lung-cancer-in-patients-with-peripheral-pulmonary-nodules-44881 https://curecurrent.com/trials/clinical-registry-for-oligometastic-disease-consolidation-therapy-debulking-prior-to-chemotherapy-or-re-irradiation-44882 https://curecurrent.com/trials/primary-tumor-resection-plus-osimertinib-in-advanced-egfr-mutant-non-small-cell-lung-cancer-44883 https://curecurrent.com/trials/ph-i-ii-trial-of-systemic-vsv-ifn-nis-in-combination-with-checkpoint-inhibitor-therapy-in-patients-with-select-solid-tum-44884 https://curecurrent.com/trials/ociperlimab-with-tislelizumab-and-chemotherapy-in-participants-with-untreated-metastatic-non-small-cell-lung-cancer-44885 https://curecurrent.com/trials/primary-tumor-resection-with-sintilimab-and-chemotherapy-in-advanced-nsclc-44886 https://curecurrent.com/trials/a-cell-free-dna-methylation-blood-based-test-for-biliary-tract-cancers-screening-44887 https://curecurrent.com/trials/observational-study-to-evaluate-the-safety-and-efficacy-of-zepzelca-injection-44888 https://curecurrent.com/trials/alg-lungcancerregistry-safro2202-44889 https://curecurrent.com/trials/assessing-ai-for-detecting-lung-nodules-and-cancer-pre-and-post-deployment-study-44890 https://curecurrent.com/trials/srs-for-nsclc-with-oligo-residual-intracranial-disease-after-first-line-3rd-generation-egfr-tki-44891 https://curecurrent.com/trials/neoadjuvant-kras-g12c-directed-therapy-with-adagrasib-mrtx849-with-or-without-nivolumab-44892 https://curecurrent.com/trials/first-line-immunotherapy-based-standard-of-care-and-local-ablative-treatments-for-oligometastatic-non-small-cell-lung-ca-44893 https://curecurrent.com/trials/special-drug-use-results-surveillance-of-tabrecta-tablets-44894 https://curecurrent.com/trials/serplulimab-combined-with-cryoablation-for-early-stage-non-small-cell-lung-cancer-44895 https://curecurrent.com/trials/prospective-observational-study-on-es-sclc-44896 https://curecurrent.com/trials/physical-functioning-throughout-lung-cancer-treatment-44897 https://curecurrent.com/trials/sequencing-of-stereotactic-ablative-body-radiotherapy-in-combination-with-pd-1-blockade-using-pembrolizumab-in-metastati-44898 https://curecurrent.com/trials/a-real-world-study-of-adebrelimab-based-combination-regimens-in-the-treatment-of-advanced-solid-tumors-44899 https://curecurrent.com/trials/deciphering-mechanisms-underlying-cancer-immunogenicity-44900 https://curecurrent.com/trials/predictive-value-of-cea-and-ctdna-in-lung-cancer-recurrence-44901 https://curecurrent.com/trials/human-papillomavirus-and-cervical-dysplasia-in-women-with-cystic-fibrosis-44902 https://curecurrent.com/trials/a-study-of-brigatinib-compared-to-alectinib-in-adults-with-non-small-cell-lung-cancer-44903 https://curecurrent.com/trials/segmentectomy-vs-lobectomy-for-2-3cm-iaslc-grade-1-2-lung-adenocarcinoma-a-multi-center-rct-44904 https://curecurrent.com/trials/observational-study-on-the-impact-of-herpes-zoster-vaccine-on-the-incidence-of-herpes-zoster-and-survival-in-lung-cancer-44905 https://curecurrent.com/trials/robotic-lobectomy-vs-thoracoscopic-lobectomy-for-early-stage-lung-cancer-rct-44906 https://curecurrent.com/trials/phase-1a-1b-study-of-tpst-1495-as-a-single-agent-and-in-combination-with-pembrolizumab-in-subjects-with-solid-tumors-44907 https://curecurrent.com/trials/fissios-and-postoperative-complications-fpoc-trial-44908 https://curecurrent.com/trials/real-world-study-on-gene-profile-in-patients-with-advanced-nsclc-who-progressed-on-first-line-osimertinib-therapy-gps-44909 https://curecurrent.com/trials/feasibility-of-immunotherapy-administration-to-patients-with-bronchial-cancer-in-a-hospital-at-home-setting-imhadom-44910 https://curecurrent.com/trials/immunotherapy-clearance-and-phenotype-of-circulating-tumor-cells-in-lung-and-head-and-neck-cancers-44911 https://curecurrent.com/trials/personalized-sbrt-in-early-stage-peripheral-nsclc-44912 https://curecurrent.com/trials/observation-or-upfront-cranial-rt-in-oncogene-mutated-nsclc-with-asymptomatic-bm-a-phase-iii-rct-44913 https://curecurrent.com/trials/a-study-of-aflibercept-versus-placebo-in-patients-with-second-line-docetaxel-for-locally-advanced-or-metastatic-non-smal-44914 https://curecurrent.com/trials/concomitant-chemo-radiotherapy-in-locally-advanced-non-small-cell-lung-cancer-44915 https://curecurrent.com/trials/first-line-treatment-in-egfr-mutation-positive-advanced-nsclc-patients-with-central-nervous-system-cns-metastases-44916 https://curecurrent.com/trials/local-consolidative-radiation-therapy-plus-tki-versus-tki-alone-in-driver-mutated-om-nsclc-44917 https://curecurrent.com/trials/taiwan-real-world-ldct-screening-behavior-and-outcome-research-for-high-risk-subjects-based-on-health-promotion-administ-44918 https://curecurrent.com/trials/efficacy-of-neoadjuvant-immunotherapy-in-patients-with-lung-cancer-44919 https://curecurrent.com/trials/a-study-evaluating-ab248-alone-or-in-combination-with-pembrolizumab-in-adult-patients-with-solid-tumors-44920 https://curecurrent.com/trials/the-cardiac-stress-and-electrocardiographic-changes-caused-by-lung-cancer-surgery-44921 https://curecurrent.com/trials/testing-c-raven-a-virtual-tobacco-cessation-intervention-in-the-community-44922 https://curecurrent.com/trials/standard-maintenance-therapy-smt-vs-local-consolidative-radiation-therapy-and-smt-in-om-nsclc-44923 https://curecurrent.com/trials/interest-of-intensive-postoperative-rehabilitation-following-minimally-invasive-lung-resection-44924 https://curecurrent.com/trials/effectiveness-of-an-enhanced-tobacco-intervention-protocol-compared-to-standard-treatment-in-helping-head-and-neck-and-l-44925 https://curecurrent.com/trials/a-study-on-the-efficacy-of-androgen-deprivation-therapy-combined-with-anti-pd-1-therapy-in-advanced-lung-cancer-44926 https://curecurrent.com/trials/safety-and-efficacy-study-of-pemetrexed-platinum-chemotherapy-pembrolizumab-mk-3475-with-or-without-lenvatinib-mk-7902-e-44927 https://curecurrent.com/trials/pharmacokinetic-study-of-ql2107-versus-keytruda-for-adjuvant-therapy-of-non-small-cell-lung-cancer-nsclc-44928 https://curecurrent.com/trials/mobile-lung-cancer-screening-44929 https://curecurrent.com/trials/ak112-in-non-squamous-non-small-cell-lung-cancer-nsclc-patients-with-actionable-genomic-alterations-aga-who-have-failed-44930 https://curecurrent.com/trials/athletic-intervention-after-thoracic-surgery-for-lung-cancer-a-pilot-study-44931 https://curecurrent.com/trials/immune-marker-platform-for-patients-with-advanced-lung-cancer-44932 https://curecurrent.com/trials/dacomitinib-in-lung-cancer-with-uncommon-egfr-mutations-44933 https://curecurrent.com/trials/assessment-of-tool-placement-in-pulmonary-nodule-s-using-a-robotic-navigational-bronchoscopy-system-44934 https://curecurrent.com/trials/nanocrystalline-megestrol-acetate-in-concurrent-chemoradiotherapy-for-locally-advanced-non-small-cell-lung-cancer-44935 https://curecurrent.com/trials/patients-with-es-sclc-and-ecog-ps-2-receiving-atezolizumab-carboplatin-etoposide-44936 https://curecurrent.com/trials/thoracic-radiotherapy-for-patients-with-metastatic-stage-iv-non-small-cell-lung-cancer-at-high-risk-of-symptomatic-progr-44937 https://curecurrent.com/trials/a-phase-i-ii-study-of-wj13404-monotherapy-in-patients-with-advanced-or-mentastatic-non-small-cell-lung-cancer-44938 https://curecurrent.com/trials/pharmacogenomics-anda-snp-clinical-study-topotecan-and-single-nucleotide-polymorphisms-44939 https://curecurrent.com/trials/a-study-to-assess-the-efficacy-of-wsd0922-fu-in-patients-with-c797s-advanced-non-small-cell-lung-cancer-44940 https://curecurrent.com/trials/effect-of-transcutaneous-acupoint-electrical-stimulation-taes-on-postoperative-cough-in-lung-cancer-44941 https://curecurrent.com/trials/vebreltinib-for-neoadjuvant-in-metex-14-skipping-mutant-stage-iia-iiib-n2-non-small-cell-lung-cancer-nsclc-44942 https://curecurrent.com/trials/impact-of-maxigesic-on-delirium-after-minimally-invasive-lung-surgery-in-elderly-patients-44943 https://curecurrent.com/trials/toripalimab-combined-with-cryoablation-for-first-line-oligo-progression-in-driver-negative-advanced-nsclc-44944 https://curecurrent.com/trials/a-study-of-eli-002-in-subjects-with-kras-mutated-pancreatic-ductal-adenocarcinoma-pdac-and-other-solid-tumors-44945 https://curecurrent.com/trials/a-study-of-hstc810-in-combination-with-paclitaxel-in-relapsed-or-refractory-extensive-stage-small-cell-lung-cancer-44946 https://curecurrent.com/trials/fluid-biopsy-for-the-diagnosis-of-lung-cancer-44947 https://curecurrent.com/trials/sirolimus-and-auranofin-in-treating-patients-with-advanced-or-recurrent-non-small-cell-lung-cancer-or-small-cell-lung-ca-44948 https://curecurrent.com/trials/decision-aid-for-the-improvement-of-decision-making-in-patients-with-non-small-cell-lung-cancer-44949 https://curecurrent.com/trials/a-feasibility-study-of-mri-guided-stereotactic-ablative-radiotherapy-midsection-44950 https://curecurrent.com/trials/cancer-rapid-diagnostics-and-immune-assessment-for-sars-cov-2-covid-19-44951 https://curecurrent.com/trials/a-study-of-morab-202-in-participants-with-previously-treated-metastatic-non-small-cell-lung-cancer-nsclc-adenocarcinoma-44952 https://curecurrent.com/trials/bozitinib-combined-with-chemotherapy-as-radical-treatment-for-stage-iia-iiic-met-altered-non-small-cell-lung-cancer-44953 https://curecurrent.com/trials/safety-and-efficacy-of-lorbrena-44954 https://curecurrent.com/trials/a-study-to-evaluate-safety-efficacy-of-ff-10832-in-combo-with-pembrolizumab-in-urothelial-non-small-cell-lung-cancer-44955 https://curecurrent.com/trials/community-exercise-treating-effect-on-cardiopulmonary-disease-patients-44956 https://curecurrent.com/trials/patient-reported-outcome-measurements-proms-impact-on-clinical-outcome-in-first-line-setting-non-small-cell-lung-cancer-44957 https://curecurrent.com/trials/an-open-label-phase-i-clinical-trial-of-super1-tcr-t-in-ny-eso-1-positive-patients-with-advanced-solid-tumors-44958 https://curecurrent.com/trials/tumor-rebiopsy-during-progression-under-immunotherapy-for-patients-with-lung-cancer-44959 https://curecurrent.com/trials/feasibility-of-rus-lung-in-mits-44960 https://curecurrent.com/trials/jsi-1187-01-monotherapy-and-in-combination-with-dabrafenib-for-advanced-solid-tumors-with-mapk-pathway-mutations-44961 https://curecurrent.com/trials/nebulized-inhalation-of-recombinant-human-p53-adenovirus-injection-for-treatment-of-multiple-ground-glass-lung-nodules-a-44962 https://curecurrent.com/trials/realmove-lung-assessing-tumour-motion-with-dynamic-mri-44963 https://curecurrent.com/trials/a-phase-1-2a-study-of-imm-1-104-in-participants-with-advanced-or-metastatic-solid-tumors-44964 https://curecurrent.com/trials/characteristics-of-advanced-lung-cancer-at-the-time-of-diagnosis-in-a-large-italian-cohor-44965 https://curecurrent.com/trials/community-support-program-for-lung-cancer-screening-44966 https://curecurrent.com/trials/real-world-clinical-outcomes-of-patients-with-early-stage-lung-cancer-after-the-surgery-44967 https://curecurrent.com/trials/preoperative-amivantamab-or-amivantamab-and-carboplatin-pemetrexed-treatment-in-patients-with-resectable-non-small-cell-44968 https://curecurrent.com/trials/clinical-study-of-al2846-capsules-in-the-treatment-of-advanced-lung-tumor-and-advanced-ovarian-cancer-44969 https://curecurrent.com/trials/tusamitamab-ravtansine-in-nsq-nsclc-participants-with-negative-or-moderate-ceacam5-expression-tumors-and-high-circulatin-44970 https://curecurrent.com/trials/study-to-evaluate-the-safety-of-pembrolizumab-in-participants-with-unresectable-or-metastatic-melanoma-or-non-small-cell-44971 https://curecurrent.com/trials/a-study-to-assess-the-efficacy-and-safety-of-wsd0922-fu-in-patients-with-egfrm-advanced-non-small-cell-lung-cancer-44972 https://curecurrent.com/trials/an-open-prospective-longitudinal-pulmonary-cardiovascular-cohort-study-44973 https://curecurrent.com/trials/surufatinib-plus-anti-pd-1-l1-as-maintenance-therapy-in-extensive-stage-small-cell-lung-cancer-44974 https://curecurrent.com/trials/radiotherapy-strategies-for-use-in-combined-treatment-of-small-cell-lung-cancer-44975 https://curecurrent.com/trials/a-study-to-evaluate-ab308-in-combination-with-ab122-in-participants-with-advanced-malignancies-44976 https://curecurrent.com/trials/a-clinica-study-of-pyrotinib-in-patients-of-advanced-non-small-cell-lung-cancer-with-her2-mutation-44977 https://curecurrent.com/trials/js001sc-or-js001-plus-chemotherapy-is-indicated-for-relapsed-or-metastatic-first-line-non-squamous-non-small-cell-lung-c-44978 https://curecurrent.com/trials/phase-1-2-trial-of-gavo-cel-tc-210-in-patients-with-advanced-mesothelin-expressing-cancer-44979 https://curecurrent.com/trials/atezolizumab-and-tiragolumab-in-patients-with-nsclc-or-advanced-solid-tumors-having-had-prior-treatment-with-a-pd-1-inhi-44980 https://curecurrent.com/trials/chemotherapy-and-immunotherapy-in-extensive-stage-small-cell-lung-cancer-with-thoracic-radiotherapy-44981 https://curecurrent.com/trials/an-umbrella-study-of-recurrent-extensive-stage-small-cell-lung-cancer-based-on-molecular-typing-44982 https://curecurrent.com/trials/an-observational-study-on-the-impact-of-the-23-valent-pneumonia-vaccine-on-lung-cancer-patients-44983 https://curecurrent.com/trials/slnd-or-not-in-ct1-ggo-invasive-lung-adenocarcinoma-ectop-1009-44984 https://curecurrent.com/trials/ldct-sc-fi-low-dose-ct-screening-for-lung-cancer-44985 https://curecurrent.com/trials/iparomlimab-and-tuvonralimab-plus-chemotherapy-for-inducing-conversion-to-resectability-in-initially-unresectable-stage-44986 https://curecurrent.com/trials/a-phase-1-2-open-label-dose-escalation-safety-study-of-incagn01949-in-subjects-with-advanced-or-metastatic-solid-tumors-44987 https://curecurrent.com/trials/dexamethasone-effects-in-patients-with-refractory-non-small-cell-lung-cancer-using-flt-positron-emission-tomography-44988 https://curecurrent.com/trials/centralized-lung-cancer-early-detection-among-smokers-clear-study-44989 https://curecurrent.com/trials/novel-thin-bronchoscope-versus-ultrathin-bronchoscope-for-the-diagnosis-of-peripheral-pulmonary-nodules-44990 https://curecurrent.com/trials/a-study-of-bl-m09d1-in-patients-with-locally-advanced-or-metastatic-non-small-cell-lung-cancer-and-other-solid-tumors-44991 https://curecurrent.com/trials/study-to-investigate-luveltamab-tazevibulin-in-adults-with-advanced-or-metastatic-non-small-cell-lung-cancer-44992 https://curecurrent.com/trials/can-2409-plus-prodrug-with-standard-of-care-immune-checkpoint-inhibitor-for-stage-iii-iv-nsclc-44993 https://curecurrent.com/trials/pembrolizumab-plus-epacadostat-vs-pembrolizumab-plus-placebo-in-metastatic-non-small-cell-lung-cancer-keynote-654-05-ech-44994 https://curecurrent.com/trials/ttfields-in-general-routine-clinical-care-in-patients-with-pleural-mesothelioma-study-44995 https://curecurrent.com/trials/ql1706-bevacizumab-chemotherapy-in-post-ici-non-squamous-nsclc-44996 https://curecurrent.com/trials/a-phase-i-ib-study-of-mek162-a-mek-inhibitor-in-combination-with-carboplatin-and-pemetrexed-in-patients-with-non-squamou-44997 https://curecurrent.com/trials/real-world-stage-ii-iii-nsclc-patients-receiving-neoadjuvant-chemo-immunotherapy-and-no-surgical-resection-44998 https://curecurrent.com/trials/irinotecan-liposome-combined-with-anlotinib-as-second-line-regimen-for-sclc-44999 https://curecurrent.com/trials/a-study-of-al8326-in-healthy-subjects-45000 https://curecurrent.com/trials/a-dose-escalation-and-expansion-study-of-lomvastomig-a-pd-1-tim-3-bispecific-antibody-in-participants-with-advanced-and-45001 https://curecurrent.com/trials/study-of-iparomlimab-and-tuvonralimab-plus-chemotherapy-in-malignant-mesothelioma-45002 https://curecurrent.com/trials/aliya-pulsed-electric-fields-pef-for-advanced-cancer-45003 https://curecurrent.com/trials/feasibility-of-intratumoral-washing-fluid-for-detecting-egfr-mutations-in-lung-cancer-45004 https://curecurrent.com/trials/symptoms-burden-in-lung-cancer-patients-undergoing-definitive-chemoradiotherapy-insights-from-electronic-patient-reporte-45005 https://curecurrent.com/trials/a-study-of-aumolertinib-in-european-participants-with-non-small-cell-lung-cancer-45006 https://curecurrent.com/trials/iparomlimab-and-tuvonralimab-combined-with-2-or-4-cycles-of-chemotherapy-as-neoadjuvant-therapy-for-resectable-nsclc-45007 https://curecurrent.com/trials/hs-it101-injection-for-advanced-nsclc-45008 https://curecurrent.com/trials/efficacy-and-safety-of-anti-pd-1-pd-l1-antibodies-in-combination-with-bevacizumab-and-metronomic-cyclophosphamide-in-pat-45009 https://curecurrent.com/trials/a-study-to-examine-biomarkers-from-lung-and-blood-samples-in-participants-with-suspected-lung-cancer-45010 https://curecurrent.com/trials/pemetrexed-platinum-with-or-without-bevacizumab-in-brain-metastases-from-patients-with-egfr-alk-negative-non-squamous-no-45011 https://curecurrent.com/trials/comparison-of-longer-term-5-year-outcomes-survival-of-smokers-ex-smokers-never-smoker-and-quitters-45012 https://curecurrent.com/trials/perioperative-cisgem-rilvegostomig-in-high-risk-resectable-intra-hepatic-cholangiocarcinoma-45013 https://curecurrent.com/trials/validation-of-the-spot-mas-lung-test-using-circulating-tumor-dna-for-the-detection-of-lung-cancer-45014 https://curecurrent.com/trials/spectalung-screening-patients-with-thoracic-tumors-for-efficient-clinical-trial-access-45015 https://curecurrent.com/trials/the-effect-of-esketamine-combined-with-dexmedetomidine-on-postoperative-recovery-quality-in-patients-undergoing-thoracos-45016 https://curecurrent.com/trials/prospect-profiling-of-resistance-patterns-oncogenic-signaling-pathways-in-evaluation-of-cancers-of-the-thorax-and-therap-45017 https://curecurrent.com/trials/efficacy-and-safety-of-pembrolizumab-mk-3475-with-lenvatinib-e7080-mk-7902-vs-docetaxel-in-participants-with-metastatic-45018 https://curecurrent.com/trials/1st-line-durvalumab-in-ps-2-nsclc-patients-45019 https://curecurrent.com/trials/prospective-evaluation-of-the-tool-in-lesion-technology-of-the-galaxy-system-in-routine-clinical-practice-45020 https://curecurrent.com/trials/resistance-to-the-tyrosine-kinase-inhibitor-osimertinib-and-pharmacokinetics-in-non-small-cell-lung-cancer-45021 https://curecurrent.com/trials/pembrolizumab-vibostolimab-coformulation-mk-7684a-or-pembrolizumab-vibostolimab-coformulation-plus-docetaxel-versus-doce-45022 https://curecurrent.com/trials/feasibility-of-bronchial-washing-fluid-for-molecular-testing-with-next-generation-sequencing-in-lung-cancer-45023 https://curecurrent.com/trials/tovorafenib-day101-or-in-combination-with-pimasertib-for-participants-with-melanoma-and-other-solid-tumors-45024 https://curecurrent.com/trials/a-study-of-the-safety-tolerability-and-efficacy-of-epacadostat-administered-in-combination-with-nivolumab-in-select-adva-45025 https://curecurrent.com/trials/the-watch-the-spot-trial-45026 https://curecurrent.com/trials/a-retrospective-cohort-analysis-of-smarca4-deficient-lung-cancer-45027 https://curecurrent.com/trials/neoadjuvant-chemotherapy-and-immunotherapy-for-a-selected-group-of-inoperable-pleural-mesothelioma-patients-necim-a-feas-45028 https://curecurrent.com/trials/selective-lymph-node-resection-for-invasive-non-small-cell-lung-cancer-with-the-ctr-of-0-5-1-and-the-diameter-of-2-cm-45029 https://curecurrent.com/trials/cryoablation-combined-with-lenvatinib-plus-ql1706-iparomlimab-tuvonralimab-in-patients-with-advanced-intrahepatic-cholan-45030 https://curecurrent.com/trials/a-perioperative-comprehensive-diagnosis-and-treatment-system-for-lung-cancer-in-the-era-of-neoadjuvant-immunotherapy-45031 https://curecurrent.com/trials/covid19-sars-vaccinations-systemic-allergic-reactions-to-sars-cov-2-vaccinations-45032 https://curecurrent.com/trials/the-natural-history-and-biological-study-of-pulmonary-recurrent-respiratory-papillomatosis-prrp-45033 https://curecurrent.com/trials/a-study-of-gfh925-in-combination-with-cetuximab-in-previously-untreated-advanced-nsclc-harboring-kras-g12c-mutation-45034 https://curecurrent.com/trials/inflammation-cachexia-and-therapeutic-response-in-lung-cancer-treated-with-immune-checkpoint-inhibitors-exploratory-obse-45035 https://curecurrent.com/trials/quebec-lung-cancer-screening-plus-trial-45036 https://curecurrent.com/trials/mr-informed-stereotactic-radiotherapy-for-treatment-of-ultracentral-lung-tumours-utilising-a-dedicated-mr-simulator-for-45037 https://curecurrent.com/trials/the-purpose-of-this-study-is-to-evaluate-the-safety-tolerability-and-efficacy-of-tmt101-injection-monotherapy-in-patient-45038 https://curecurrent.com/trials/d-0316-versus-icotinib-in-patients-with-locally-advanced-or-metastatic-egfr-sensitising-mutation-positive-nsclc-45039 https://curecurrent.com/trials/lung-cancer-screening-in-family-members-and-peers-of-lung-cancer-patients-a-prospective-cohort-study-45040 https://curecurrent.com/trials/safety-study-of-enoblituzumab-mga271-in-combination-with-pembrolizumab-or-mga012-in-refractory-cancer-45041 https://curecurrent.com/trials/immunocare-rapid-accurate-covid-testing-to-reduce-hospitalization-of-immunocompromised-individuals-45042 https://curecurrent.com/trials/efficacy-comparison-of-dostarlimab-plus-chemotherapy-versus-pembrolizumab-plus-chemotherapy-in-participants-with-metasta-45043 https://curecurrent.com/trials/survival-efficacy-of-combined-radiotherapy-and-immunotherapy-in-patients-with-metastatic-non-small-cell-lung-carcinoma-45044 https://curecurrent.com/trials/bnt162b2-messenger-ribonucleic-acid-mrna-covid-19-vaccine-in-cancer-patients-on-active-treatment-45045 https://curecurrent.com/trials/dna-evaluation-of-fragments-for-early-interception-lung-cancer-training-study-delfi-l101-study-45046 https://curecurrent.com/trials/development-of-innovative-preclinical-ex-vivo-models-for-the-study-of-sarcomas-and-metastases-from-solid-tumors-45047 https://curecurrent.com/trials/datopotamab-deruxtecan-dato-dxd-for-non-small-cell-lung-cancer-nsclc-patients-with-active-brain-metastases-45048 https://curecurrent.com/trials/evaluation-of-the-feasibility-and-clinical-relevance-of-liquid-biopsy-in-patients-with-suspicious-metastatic-lung-cancer-45049 https://curecurrent.com/trials/press-needle-acupuncture-for-pain-and-quality-of-life-in-lung-cancer-patients-45050 https://curecurrent.com/trials/pembrolizumab-plus-bevacizumab-for-treatment-of-brain-metastases-in-metastatic-melanoma-or-non-small-cell-lung-cancer-ns-45051 https://curecurrent.com/trials/a-single-center-phase-ii-clinical-trial-evaluating-the-efficacy-of-sacituzumab-tirumotecan-in-combination-with-tagitanli-45052 https://curecurrent.com/trials/randomized-trial-of-glutathione-with-anti-pd-1-and-chemotherapy-in-advanced-nsclc-45053 https://curecurrent.com/trials/a-clinical-study-of-bt02-in-treating-patients-with-advanced-lung-cancer-45054 https://curecurrent.com/trials/perioperative-immunotherapy-for-resectable-limited-stage-sclc-45055 https://curecurrent.com/trials/toripalimab-combined-with-chemotherapy-as-adjuvant-therapy-for-non-small-cell-lung-cancer-with-or-without-prior-neoadjuv-45056 https://curecurrent.com/trials/aerosolized-sargramostim-added-to-immunotherapy-for-the-treatment-of-patients-with-metastatic-melanoma-to-the-lung-45057 https://curecurrent.com/trials/ai-based-deepgem-tool-for-predicting-gene-mutations-in-nsclc-patients-a-randomized-controlled-study-45058 https://curecurrent.com/trials/a-clinical-study-to-evaluate-the-efficacy-and-safety-of-hlx26-anti-lag-3-monoclonal-antibody-injection-combined-with-ser-45059 https://curecurrent.com/trials/comparison-of-double-lumen-tube-location-verification-techniques-in-single-lung-ventilation-45060 https://curecurrent.com/trials/multimodal-large-model-driven-risk-and-prognosis-assessment-for-brain-metastases-in-lung-cancer-45061 https://curecurrent.com/trials/organoid-guided-vs-topotecan-therapy-in-relapsed-extensive-stage-small-cell-lung-cancer-45062 https://curecurrent.com/trials/ai-models-for-predicting-occult-pleural-dissemination-in-nsclc-45063 https://curecurrent.com/trials/a-phase-1-dose-escalation-study-of-zg006-in-patients-with-small-cell-lung-cancer-45064 https://curecurrent.com/trials/study-to-evaluate-the-efficacy-and-safety-of-pemigatinib-in-participants-with-relapsed-or-refractory-advanced-non-small-45065 https://curecurrent.com/trials/clinical-validation-of-freenome-multiomics-blood-test-for-lung-cancer-screening-45066 https://curecurrent.com/trials/a-study-evaluating-concurrent-chemoradiotherapy-combined-with-dual-immune-checkpoint-blockade-for-limited-stage-small-ce-45067 https://curecurrent.com/trials/arginase-inhibitor-incb001158-as-a-single-agent-and-in-combination-with-immune-checkpoint-therapy-in-patients-with-advan-45068 https://curecurrent.com/trials/sweep-shuttle-walking-test-for-exercise-evaluation-in-pulmonary-resection-45069 https://curecurrent.com/trials/observational-prospective-study-of-quality-of-life-in-unresectable-tnm-stage-iii-nsclc-obstinate-45070 https://curecurrent.com/trials/a-prospective-multicenter-clinical-study-of-hetrombopag-in-the-prevention-of-thrombocytopenia-caused-by-lung-cancer-ther-45071 https://curecurrent.com/trials/to-evaluate-obi-833-obi-821-in-combination-with-first-line-erlotinib-in-patients-with-egfr-mutated-globo-h-positive-loca-45072 https://curecurrent.com/trials/study-of-inupadenant-eos100850-with-chemotherapy-as-second-line-treatment-for-nonsquamous-non-small-cell-lung-cancer-45073 https://curecurrent.com/trials/a-study-of-real-world-treatment-patterns-and-outcomes-in-chinese-advanced-nsclc-patients-who-previously-received-at-leas-45074 https://curecurrent.com/trials/spinal-metastasis-as-the-first-presentation-of-lung-malignancy-clinical-characteristics-and-postoperative-survival-45075 https://curecurrent.com/trials/perioperative-study-of-iparomlimab-and-tuvonralimab-in-resectable-nsclc-45076 https://curecurrent.com/trials/toripalimab-combined-with-chemotherapy-as-adjuvant-therapy-for-incidental-small-cell-lung-cancer-after-radical-resection-45077 https://curecurrent.com/trials/pan-canadian-lung-cancer-observational-study-paleos-45078 https://curecurrent.com/trials/prognostic-value-of-sarcopenia-and-nutritional-status-in-early-stage-non-small-cell-lung-cancer-45079 https://curecurrent.com/trials/a-clinical-evaluation-of-the-aliya-system-in-late-stage-cancer-45080 https://curecurrent.com/trials/feasibility-of-cbct-guided-online-adaptive-radiotherapy-fascinate-45081 https://curecurrent.com/trials/the-lung-health-check-pilot-45082 https://curecurrent.com/trials/taxoprexin-plus-carboplatin-treatment-for-advanced-lung-cancer-45083 https://curecurrent.com/trials/a-study-of-hs-20117-combined-with-aumolertinib-in-participants-with-advanced-non-squamous-non-small-cell-lung-cancer-45084 https://curecurrent.com/trials/subcostal-single-port-versus-intercostal-multi-port-robotic-lobectomy-for-non-small-cell-lung-cancer-45085 https://curecurrent.com/trials/plasma-metabolomics-as-a-tool-to-distinguish-pet-positive-malignant-from-pet-positive-benign-nodules-45086 https://curecurrent.com/trials/sdtm001-injection-as-adjuvant-therapy-for-nsclc-patients-after-radical-surgical-resection-45087 https://curecurrent.com/trials/intra-operative-air-leak-management-after-minimally-invasive-lung-segmental-resection-45088 https://curecurrent.com/trials/empathy-nsclc-european-registry-for-plasma-based-molecular-profiling-in-advanced-nsclc-patients-45089 https://curecurrent.com/trials/pain-control-after-vats-anatomical-pulmonary-resections-45090 https://curecurrent.com/trials/intraoperative-blood-pressure-management-and-dexamethasone-in-lung-cancer-surgery-45091 https://curecurrent.com/trials/a-study-of-brigatinib-in-participants-with-anaplastic-lymphoma-kinase-positive-alk-advanced-non-small-cell-lung-cancer-n-45092 https://curecurrent.com/trials/role-of-mdscs-and-cancer-stem-cells-and-their-cross-talks-in-nsclc-45093 https://curecurrent.com/trials/hla-typing-tumor-neoantigen-identification-for-phase-i-ii-study-of-autologous-tcr-t-cells-in-subjects-with-solid-tumors-45094 https://curecurrent.com/trials/consolidation-radiotherapy-vs-observation-in-oligoresidual-advanced-non-small-cell-lung-cancer-after-chemo-immunotherapy-45095 https://curecurrent.com/trials/phase-i-study-of-autologous-cd8-and-cd4-engineered-t-cell-receptor-t-cells-in-subjects-with-advanced-or-metastatic-solid-45096 https://curecurrent.com/trials/long-term-follow-up-study-of-subjects-treated-with-autologous-t-cells-using-the-sleeping-beauty-system-to-express-tcrs-45097 https://curecurrent.com/trials/efficacy-and-safety-analysis-of-first-line-abcp-therapy-in-advanced-smarca4-mutated-nsclc-45098 https://curecurrent.com/trials/follow-up-of-patients-with-curative-intent-surgical-resection-for-nsclc-45099 https://curecurrent.com/trials/camu-camu-prebiotic-and-immune-checkpoint-inhibition-in-patients-with-non-small-cell-lung-cancer-and-melanoma-45100 https://curecurrent.com/trials/iadademstat-in-combination-with-paclitaxel-in-relapsed-refractory-sclc-and-extrapulmonary-high-grade-net-45101 https://curecurrent.com/trials/role-of-cancer-associated-fibroblast-mdscs-and-immune-cell-interplays-in-the-resistance-of-non-small-cell-lung-cancer-to-45102 https://curecurrent.com/trials/a-real-world-study-of-adjuvant-therapy-in-early-stage-nsclc-with-egfr-mutation-positive-in-china-45103 https://curecurrent.com/trials/a-study-to-evaluate-pembrolizumab-plus-lenvatinib-in-pd-l1-positive-tki-resistant-nsclc-patients-45104 https://curecurrent.com/trials/effect-of-g-csf-on-mdsc-and-cancer-stem-cells-interactions-in-non-small-cell-lung-cancers-circuit-45105 https://curecurrent.com/trials/study-of-gt103-in-combination-with-pembrolizumab-in-refractory-metastatic-non-small-cell-lung-cancer-45106 https://curecurrent.com/trials/ttx-030-in-combination-with-immunotherapy-and-or-chemotherapy-in-subjects-with-advanced-cancers-45107 https://curecurrent.com/trials/principle-test-for-isolation-and-characterization-of-circulating-cancer-cells-ctc-cxcr4-45108 https://curecurrent.com/trials/image-navigated-resection-of-lung-nodules-45109 https://curecurrent.com/trials/immunotherapy-with-non-ablative-radiation-in-previously-untreated-patients-with-stage-iv-nsclc-45110 https://curecurrent.com/trials/nano-crystalline-megestrol-acetate-for-anorexia-cachexia-syndrome-in-advanced-lung-cancer-45111 https://curecurrent.com/trials/nab-paclitaxel-with-gemcitabine-for-relapsed-small-cell-cancer-45112 https://curecurrent.com/trials/vargado-vargatef-in-2nd-line-therapy-of-non-small-cell-lung-cancer-nsclc-45113 https://curecurrent.com/trials/use-of-chinese-herbal-formula-shu-yu-wan-in-lung-cancer-patients-45114 https://curecurrent.com/trials/drug-drug-interaction-study-of-tak-788-and-midazolam-in-participants-with-advanced-non-small-cell-lung-cancer-nsclc-45115 https://curecurrent.com/trials/phase-ib-ii-study-of-vebreltinib-with-furmonertinib-in-nsclc-patients-with-c-met-amplification-after-egfr-tki-failure-45116 https://curecurrent.com/trials/combination-of-concurrent-chemoradiotherapy-with-surufatinib-and-tislelizumab-in-patients-with-locally-advanced-non-smal-45117 https://curecurrent.com/trials/electroacupuncture-combined-with-pd-1-inhibitor-for-elderly-patients-with-advanced-nsclc-45118 https://curecurrent.com/trials/tislelizumab-combined-with-scrt-in-stage-iiib-c-iv-non-squamous-non-small-cell-lung-cancer-a-prospective-single-arm-phas-45119 https://curecurrent.com/trials/phase-i-ii-study-of-plb1004-combined-with-platinum-based-doublet-chemotherapy-in-patients-with-egfr-mutation-positive-45120 https://curecurrent.com/trials/perioperative-treatment-of-sunvozertinib-in-stage-ii-iiib-nsclc-45121 https://curecurrent.com/trials/acupuncture-for-lung-cancer-related-fatigue-45122 https://curecurrent.com/trials/open-label-surufatinib-in-european-patients-with-net-45123 https://curecurrent.com/trials/a-phase-ii-randomized-trial-of-neoadjuvant-ivonescimab-or-penpulimab-plus-chemotherapy-in-resectable-nsclc-45124 https://curecurrent.com/trials/development-of-clinical-and-biological-database-on-bronchial-cancer-45125 https://curecurrent.com/trials/pharmaco-economic-study-of-a-second-line-treatment-in-advanced-non-small-cell-lung-cancer-45126 https://curecurrent.com/trials/a-study-of-nivolumab-and-ipilimumab-in-untreated-participants-with-stage-3-non-small-cell-lung-cancer-nsclc-that-is-unab-45127 https://curecurrent.com/trials/a-phase-i-study-of-xzp-3621-in-chinese-patients-with-alk-or-ros1-rearrangement-non-small-cell-lung-cancer-45128 https://curecurrent.com/trials/lorlatinib-in-ros1-nsclc-with-brain-metastasis-45129 https://curecurrent.com/trials/acupuncture-combined-with-pd-1-pd-l1-inhibitors-for-advanced-lung-cancer-45130 https://curecurrent.com/trials/a-phase-ii-study-of-ql1706-with-anti-angiogenesis-therapy-and-chemotherapy-in-extensive-stage-small-cell-lung-cancer-45131 https://curecurrent.com/trials/neoadjuvant-immunotherapy-plus-chemotherapy-followed-by-concurrent-chemoradiotherapy-and-consolidative-immunotherapy-for-45132 https://curecurrent.com/trials/expanded-access-protocol-for-the-use-of-sl-28-in-the-treatment-of-advanced-solid-tumors-45133 https://curecurrent.com/trials/pet-ct-based-image-analysis-and-machine-learning-of-hypermetabolic-pulmonary-lesions-45134 https://curecurrent.com/trials/x-396-ensartinib-capsules-in-alk-positive-nsclc-patients-with-brain-metastases-45135 https://curecurrent.com/trials/a-study-of-bl-b01d1-and-almonertinib-in-patients-with-resectable-egfr-stage-ii-iiib-nsclc-45136 https://curecurrent.com/trials/hypofractionated-versus-conventional-chemoradiotherapy-followed-by-consolidative-immunotherapy-in-locally-advanced-nsclc-45137 https://curecurrent.com/trials/pembrolizumab-and-chemotherapy-neoadjuvant-adjuvant-of-nsclc-45138 https://curecurrent.com/trials/tracking-t-cell-responses-to-evaluate-pembrolizumab-effectiveness-in-advanced-non-small-cell-lung-cancer-45139 https://curecurrent.com/trials/a-randomized-controlled-trial-evaluating-the-effectiveness-of-a-novel-risk-stratified-screening-strategy-for-lung-cancer-45140 https://curecurrent.com/trials/real-world-study-evaluating-the-long-term-outcomes-of-pegylated-interferon-2b-treatment-in-the-families-with-clusters-of-45141 https://curecurrent.com/trials/real-world-study-of-taletrectinib-for-advanced-ros1-nsclc-with-brain-metastases-45142 https://curecurrent.com/trials/pemetrexed-and-carboplatin-with-or-without-anlotinib-hydrochloride-for-osimertinib-resistant-non-squamous-nsclc-45143 https://curecurrent.com/trials/a-study-on-exploring-the-abscopal-effect-induced-by-different-radioimmunotherapy-combination-patterns-in-the-treatment-o-45144 https://curecurrent.com/trials/a-study-of-bms-986466-with-adagrasib-with-or-without-cetuximab-in-participants-with-kirsten-rat-sarcoma-virus-glycine-12-45145 https://curecurrent.com/trials/a-study-in-patients-with-braf-v600e-mutant-metastatic-non-small-cell-lung-cancer-octopus-45146 https://curecurrent.com/trials/prophylactic-proton-pump-inhibition-for-esophageal-protection-in-lung-radiation-therapy-45147 https://curecurrent.com/trials/standard-of-care-systemic-therapy-with-or-without-local-therapy-in-patients-with-oligoprogressive-non-small-cell-lung-ca-45148 https://curecurrent.com/trials/a-phase-ii-iii-study-of-ibb0979-in-combination-with-topotecan-versus-topotecan-in-relapsed-small-cell-lung-cancer-45149 https://curecurrent.com/trials/ipilimumab-and-nivolumab-in-recurrent-extensive-stage-small-cell-lung-cancer-after-receiving-platinum-based-chemotherapy-45150 https://curecurrent.com/trials/vaccination-of-advanced-stage-lung-cancer-patients-45151 https://curecurrent.com/trials/streamlining-radioembolization-for-intrahepatic-cholangiocarcinoma-45152 https://curecurrent.com/trials/transthoracic-vs-transbronchial-cryoablation-for-early-stage-peripheral-lung-cancer-45153 https://curecurrent.com/trials/transbronchial-mwa-for-pulmonary-tumors-45154 https://curecurrent.com/trials/specimen-and-clinical-data-collection-plan-for-ldct-screening-participants-45155 https://curecurrent.com/trials/deb-bace-for-primary-lung-cancer-a-retrospective-single-arm-multicenter-study-on-efficacy-and-safety-45156 https://curecurrent.com/trials/afatinib-combined-with-chemotherapy-as-conversion-therapy-in-unresectable-egfr-sensitive-mutation-positive-stage-iii-nsc-45157 https://curecurrent.com/trials/effect-of-mobile-augmented-reality-counseling-on-improving-shared-decision-making-in-thoracic-surgery-45158 https://curecurrent.com/trials/on-treatment-biomarkers-in-metastatic-colorectal-cancer-for-life-45159 https://curecurrent.com/trials/naloxegol-in-treating-patients-with-stage-iiib-iv-non-small-cell-lung-cancer-45160 https://curecurrent.com/trials/mediastinal-ebus-cryobiopsy-study-in-sweden-45161 https://curecurrent.com/trials/small-extracellular-vesicle-mirnas-as-predictive-biomarkers-for-immunochemotherapy-efficacy-in-extensive-stage-small-cel-45162 https://curecurrent.com/trials/analysis-of-circulating-tumor-dna-dynamics-to-predict-and-monitor-response-to-tki-in-patients-with-advanced-nsclc-45163 https://curecurrent.com/trials/srs-srt-hypo-rt-versus-ha-wbrt-for-no-more-than-10-brain-metastases-in-sclc-45164 https://curecurrent.com/trials/a-phase-study-of-rc108-in-combination-with-furmonertinib-for-the-first-line-treatment-of-egfr-mutated-combined-met-posit-45165 https://curecurrent.com/trials/study-of-an-early-change-of-a-chemotherapeutic-doublet-versus-four-cycles-of-chemotherapy-in-advanced-non-small-cell-lun-45166 https://curecurrent.com/trials/a-study-on-the-first-line-treatment-of-small-cell-lung-cancer-with-adebrelimab-and-vunakizumab-and-chemotherapy-45167 https://curecurrent.com/trials/combination-chemotherapy-with-or-without-surgery-chemoradiotherapy-in-patients-with-malignant-pleural-mesothelioma-45168 https://curecurrent.com/trials/epione-guided-lung-evaluation-45169 https://curecurrent.com/trials/tislelizumab-combined-with-recombinant-human-endostatin-combined-with-chemotherapy-for-unresectable-stage-iii-non-small-45170 https://curecurrent.com/trials/safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-incb099280-in-participants-with-advanced-solid-tumors-45171 https://curecurrent.com/trials/efficacy-and-safety-of-super-hyperfractionation-pulse-radiotherapy-combined-with-icis-for-advanced-nsclc-45172 https://curecurrent.com/trials/a-prospective-phase-ii-study-of-postoperative-concurrent-chemoradiotherapy-in-patients-with-intrahepatic-cholangiocarcin-45173 https://curecurrent.com/trials/an-observational-clinical-study-of-stereotactic-radiotherapy-for-advanced-non-small-cell-lung-cancer-with-stable-disease-45174 https://curecurrent.com/trials/phase-1-study-of-hs-20093-combinations-in-patients-with-extensive-stage-small-cell-lung-cancer-45175 https://curecurrent.com/trials/lung-cancer-screening-of-family-members-of-patients-with-mutation-driven-lung-cancer-45176 https://curecurrent.com/trials/study-on-the-optimal-combination-pattern-of-the-combined-treatment-of-radiotherapy-and-immunotherapy-for-the-abscopal-ef-45177 https://curecurrent.com/trials/phase-i-study-of-jyp0322-in-ros1-fusion-positive-solid-tumors-45178 https://curecurrent.com/trials/omitting-clinical-target-volume-in-radical-treatment-of-unresectable-stage-iii-non-small-cell-lung-cancer-45179 https://curecurrent.com/trials/ramucirumab-and-pembrolizumab-for-the-treatment-of-egfr-mutant-recurrent-or-metastatic-non-small-cell-lung-cancer-45180 https://curecurrent.com/trials/relationship-of-nutritional-status-to-chemotherapy-treatment-completion-and-outcomes-in-cancer-patients-45181 https://curecurrent.com/trials/predicting-immunotherapy-response-and-survival-of-lung-cancer-patients-using-artificial-intelligence-and-radiomics-radio-45182 https://curecurrent.com/trials/the-effect-of-semi-recumbent-position-on-hypoxemia-after-lung-segment-lobe-surgery-45183 https://curecurrent.com/trials/prognostic-value-of-mir-21-and-mir-486-in-pulmonary-nodule-surgery-45184 https://curecurrent.com/trials/intratumoral-gene-mediated-cytotoxic-immunotherapy-in-patients-with-resectable-non-small-cell-lung-cancer-45185 https://curecurrent.com/trials/study-of-front-line-pembrolizumab-and-valemetostat-in-pd-l1-positive-hpv-negative-recurrent-metastatic-squamous-cell-car-45186 https://curecurrent.com/trials/89zr-girentuximab-for-pet-imaging-of-caix-positive-solid-tumors-45187 https://curecurrent.com/trials/personalized-dc-vaccines-in-non-small-cell-lung-cancer-45188 https://curecurrent.com/trials/radiation-therapy-followed-by-tislelizumab-and-anlotinib-aeoadjuvant-adjuvant-therapy-for-stage-ii-iiia-nsclc-45189 https://curecurrent.com/trials/hybrid-apc-therapy-in-early-central-lung-neoplasms-45190 https://curecurrent.com/trials/phase-i-study-of-bc008-1a-injection-in-patients-with-advanced-solid-tumors-45191 https://curecurrent.com/trials/study-of-atezolizumab-in-advanced-non-oncogene-addicted-nsclc-with-pd-l1-50-including-longitudinal-c-flip-assessment-in-45192 https://curecurrent.com/trials/a-clinical-trial-of-tg6050-in-patients-with-metastatic-non-small-cell-lung-cancer-delivir-45193 https://curecurrent.com/trials/robotic-assisted-navigation-for-lung-nodule-localization-a-non-inferiority-study-45194 https://curecurrent.com/trials/a-multi-tumor-open-phase-i-clinical-study-on-the-progression-of-first-line-anti-tumor-therapy-using-cardonizumab-combine-45195 https://curecurrent.com/trials/multiple-omics-sequencing-technologies-in-predicting-the-efficacy-and-monitoring-the-recurrence-of-non-small-cell-lung-c-45196 https://curecurrent.com/trials/research-on-new-diagnosis-and-treatment-technologies-for-early-lung-cancer-45197 https://curecurrent.com/trials/dacomitinib-plus-pd-0325901-in-advanced-kras-mutant-nsclc-45198 https://curecurrent.com/trials/single-nucleotide-polymorphism-snp-study-icorg-08-40-v4-45199 https://curecurrent.com/trials/efficacy-of-argon-helium-cryoablation-plus-pd-1-inhibitors-in-nsclc-45200 https://curecurrent.com/trials/a-safety-study-of-212pb-pentixather-radioligand-therapy-45201 https://curecurrent.com/trials/a-retrospective-real-world-study-on-the-efficacy-and-safety-of-anlotinib-hydrochloride-combined-with-immunotherapy-maint-45202 https://curecurrent.com/trials/tumor-associated-neutrophils-as-a-biomarker-of-chemo-immunotherapy-response-in-locally-advanced-non-small-cell-lung-canc-45203 https://curecurrent.com/trials/pembrolizumab-vibostolimab-mk-7684a-or-atezolizumab-in-combination-with-chemotherapy-in-first-line-treatment-of-extensiv-45204 https://curecurrent.com/trials/lapatinib-plus-trametinib-in-kras-mutant-nsclc-45205 https://curecurrent.com/trials/clinical-evaluation-of-the-lung-cancer-ai-based-decision-support-tool-in-low-dose-lung-ct-45206 https://curecurrent.com/trials/intercostal-cryoanalgesia-for-chronic-pain-after-vats-lung-resection-45207 https://curecurrent.com/trials/elderly-with-locally-advanced-lung-cancer-deciding-through-geriatric-assessment-on-the-optimal-treatment-strategy-45208 https://curecurrent.com/trials/the-neuroendocrine-effects-of-pioglitazone-in-patients-with-cancer-and-cachexia-45209 https://curecurrent.com/trials/intercostal-cryoanalgesia-for-acute-pain-after-vats-lung-resection-45210 https://curecurrent.com/trials/phase-ii-study-of-shr-1210-anti-pd-1-antibody-combination-with-apatinib-versus-pemetrexed-and-carboplatin-in-subjects-wi-45211 https://curecurrent.com/trials/platform-trial-of-novel-regimens-versus-standard-of-care-soc-in-participants-with-non-small-cell-lung-cancer-nsclc-sub-s-45212 https://curecurrent.com/trials/rapid-absorbance-based-detection-of-inner-cheek-cell-abnormalities-using-light-spectroscopy-for-risk-evaluation-of-lung-45213 https://curecurrent.com/trials/the-diagnostic-accuracy-and-clinical-value-of-fapi-pet-in-pleural-mesothelioma-45214 https://curecurrent.com/trials/medical-access-program-for-datopotamab-deruxtecan-in-egfrm-nsclc-patients-45215 https://curecurrent.com/trials/goal-directed-fluid-therapy-for-thoracoscopic-lobectomy-45216 https://curecurrent.com/trials/evidence-based-nursing-for-psychological-resilience-in-lung-cancer-chemotherapy-patients-45217 https://curecurrent.com/trials/study-of-intravenous-iv-abbv-637-alone-or-in-combination-with-iv-docetaxel-osimertinib-to-assess-adverse-events-and-chan-45218 https://curecurrent.com/trials/low-dose-nivolumab-with-chemotherapy-vs-standard-chemotherapy-as-first-line-treatment-in-advanced-or-metastatic-nsclc-45219 https://curecurrent.com/trials/evidence-based-nursing-for-fatigue-and-quality-of-life-in-lung-cancer-chemotherapy-45220 https://curecurrent.com/trials/cisplatin-carboplatin-and-etoposide-with-or-without-nivolumab-in-treating-patients-with-extensive-stage-small-cell-lung-45221 https://curecurrent.com/trials/microbiota-transplant-to-cancer-patients-who-have-failed-immunotherapy-using-faeces-from-clinical-responders-45222 https://curecurrent.com/trials/fih-trial-of-vert-002-in-patients-with-locally-advanced-or-metastatic-solid-tumors-with-met-alterations-45223 https://curecurrent.com/trials/multi-omics-detection-techniques-for-differentiating-benign-and-malignant-pulmonary-nodules-45224 https://curecurrent.com/trials/vinorelbine-in-treating-patients-with-advanced-solid-tumors-that-have-not-responded-to-treatment-and-liver-dysfunction-45225 https://curecurrent.com/trials/ttx-030-single-agent-and-in-combination-with-immunotherapy-or-chemotherapy-for-patients-with-advanced-cancers-45226 https://curecurrent.com/trials/18f-f-arag-total-body-pet-imaging-and-healthy-subjects-and-lung-cancer-patients-45227 https://curecurrent.com/trials/prostep-a-feasibility-trial-using-pros-and-step-data-to-monitor-patients-with-lung-and-gi-cancers-45228 https://curecurrent.com/trials/clinical-safty-and-efficacy-study-of-infusion-of-inkt-cells-and-cd8-t-cells-in-patients-with-advanced-solid-tumor-45229 https://curecurrent.com/trials/pank-003-cell-injection-combined-with-standard-adjuvant-chemotherapy-after-surgery-in-patients-with-stage-iiia-nsclc-45230 https://curecurrent.com/trials/a-phase-ib-study-of-jmkx001899-in-combination-with-other-therapies-in-advanced-nsclc-harboring-kras-g12c-mutation-45231 https://curecurrent.com/trials/assessment-the-effectiveness-of-btva-in-copd-and-ablation-in-pulmonary-nodules-by-pulmonary-mri-45232 https://curecurrent.com/trials/primary-resistance-mechanisms-of-alk-tkis-45233 https://curecurrent.com/trials/a-multicenter-study-in-bronchoscopy-combining-stimulated-raman-histology-with-artificial-intelligence-for-rapid-lung-can-45234 https://curecurrent.com/trials/a-study-to-investigate-lyl845-in-adults-with-solid-tumors-45235 https://curecurrent.com/trials/effect-of-bilateral-vs-unilateral-alveolar-recruitment-on-gas-exchange-in-lung-resection-45236 https://curecurrent.com/trials/effects-of-different-preoperative-oral-rehydration-protocols-in-undergoing-thoracoscopic-radical-lung-cancer-surgery-45237 https://curecurrent.com/trials/a-confirmatory-clinical-study-in-nsclc-patients-with-met-exon-14-mutation-kunpeng-2-45238 https://curecurrent.com/trials/prospective-multicenter-cohort-study-for-the-development-and-evaluation-of-risk-stratification-tools-for-lung-cancers-an-45239 https://curecurrent.com/trials/a-clinical-study-of-si-b001-combined-with-docetaxel-in-the-treatment-of-non-small-cell-lung-adenocarcinoma-and-lung-squa-45240 https://curecurrent.com/trials/exercise-and-nutrition-on-early-stage-nsclc-outcomes-the-starlight-study-45241 https://curecurrent.com/trials/a-study-of-fluzoparib-shr-3162-and-temozolomide-with-or-without-shr-1316-in-treating-patients-with-replapsed-small-cell-45242 https://curecurrent.com/trials/tislelizumab-in-combination-with-sitravatinib-in-participants-with-locally-advanced-or-metastatic-non-small-cell-lung-ca-45243 https://curecurrent.com/trials/risk-and-prognosis-of-brain-metastasis-in-non-small-cell-lung-cancer-45244 https://curecurrent.com/trials/a-prospective-single-arm-phase-ii-clinical-study-of-tislelizumab-combined-with-anlotinib-and-platinum-based-doublet-peri-45245 https://curecurrent.com/trials/apl-101-study-of-subjects-with-nsclc-with-c-met-exon-14-skip-mutations-and-c-met-dysregulation-advanced-solid-tumors-45246 https://curecurrent.com/trials/clinical-outcomes-of-tislelizumab-combined-with-chemotherapy-as-induction-therapy-in-stage-iii-ctnm-iiib-iiic-nsclc-45247 https://curecurrent.com/trials/a-nutritional-supplement-to-support-people-with-non-small-cell-lung-cancer-45248 https://curecurrent.com/trials/oral-metronomic-vinorelbine-and-pd-1-inhibitors-in-elderly-non-small-cell-lung-cancer-45249 https://curecurrent.com/trials/the-impact-of-ai-assistance-on-radiologist-performance-and-healthcare-costs-in-ldct-based-lung-cancer-screening-45250 https://curecurrent.com/trials/a-multicenter-phase-ii-randomized-trial-of-limertinib-followed-by-sintilimab-and-chemotherapy-vs-limertinib-followed-by-45251 https://curecurrent.com/trials/outpatient-pulmonary-rehabilitation-in-non-small-cell-lung-cancer-receiving-immunotherapy-45252 https://curecurrent.com/trials/radiotherapy-or-observation-of-liver-metastases-in-small-cell-lung-cancer-45253 https://curecurrent.com/trials/neoadjuvant-sugemalimab-chemotherapy-followed-by-adjuvant-sugemalimab-for-patients-with-resectable-stage-ii-iiia-non-sma-45254 https://curecurrent.com/trials/early-palliative-care-in-patients-with-advanced-lung-cancer-using-an-e-health-ecosystem-45255 https://curecurrent.com/trials/neoadjuvant-and-adjuvant-therapy-studies-of-sindilizumab-in-resectable-lung-cancer-45256 https://curecurrent.com/trials/similar-efficacy-safety-and-immunogenicity-of-fyb206-in-comparison-to-keytruda-as-add-on-to-chemotherapy-in-patients-wit-45257 https://curecurrent.com/trials/feasibility-of-an-early-palliative-care-intervention-for-metastatic-cancer-patients-a-phase-2-study-45258 https://curecurrent.com/trials/cx3cr1-t-cell-predict-immunotherapy-efficacy-45259 https://curecurrent.com/trials/maintenance-pembrolizumab-at-usual-or-low-dose-in-non-squamous-lung-cancer-a-non-inferiority-study-45260 https://curecurrent.com/trials/adebrelimab-chemotherapy-as-neoadjuvant-therapy-for-resectable-nsclc-45261 https://curecurrent.com/trials/enteral-nutrition-with-l-carnitine-for-cachexia-in-non-small-cell-lung-cancer-45262 https://curecurrent.com/trials/interstitial-pneumonitis-associated-with-egfr-tki-and-combined-with-pd-1-pd-l1-45263 https://curecurrent.com/trials/digital-outreach-intervention-for-lung-cancer-screening-45264 https://curecurrent.com/trials/xentuzumab-bi-836845-plus-afatinib-in-patients-with-epidermal-growth-factor-receptor-egfr-mutant-non-small-cell-lung-can-45265 https://curecurrent.com/trials/efficacy-and-safety-of-chemoimmunotherapy-and-carbon-ion-radiotherapy-in-unresectable-locally-advanced-non-small-cell-lu-45266 https://curecurrent.com/trials/diagnosis-of-multiple-cancer-and-monitoring-of-minimal-residual-tumors-after-treatment-using-blood-and-high-sensitivity-45267 https://curecurrent.com/trials/evaluation-of-a-new-open-source-virtual-bronchoscope-navigation-system-45268 https://curecurrent.com/trials/poly-iclc-hiltonol-vaccine-in-malignant-pleural-mesothelioma-45269 https://curecurrent.com/trials/a-first-in-human-study-to-evaluate-the-safety-tolerability-and-pharmacokinetics-of-ds-6051b-45270 https://curecurrent.com/trials/pembrolizumab-and-olaparib-treatment-of-extensive-small-cell-lung-cancer-es-sclc-45271 https://curecurrent.com/trials/ssgj-707-in-advanced-non-small-cell-lung-cancer-45272 https://curecurrent.com/trials/a-study-evaluating-the-efficacy-of-pd-1-inhibitor-combined-with-denosumab-and-chemotherapy-in-locally-advanced-or-metast-45273 https://curecurrent.com/trials/nintedanib-in-molecularly-selected-patients-with-advanced-non-small-cell-lung-cancer-45274 https://curecurrent.com/trials/active-cycle-of-breathing-techniques-on-respiratory-distress-symptom-cluster-45275 https://curecurrent.com/trials/real-world-durvalumab-in-extensive-stage-small-cell-lung-cancer-45276 https://curecurrent.com/trials/electroacupuncture-combined-with-immune-checkpoint-inhibitors-as-adjuvant-therapy-after-surgery-for-early-stage-non-smal-45277 https://curecurrent.com/trials/her3-dxd-patritumab-deruxtecan-u3-1402-in-combination-with-osimertinib-in-subjects-with-locally-advanced-or-metastatic-e-45278 https://curecurrent.com/trials/complication-and-lung-function-impairment-prediction-using-perfusion-and-ct-air-trapping-45279 https://curecurrent.com/trials/study-to-compare-furmonertinib-to-platinum-based-chemotherapy-for-patients-with-locally-advanced-or-metastatic-non-small-45280 https://curecurrent.com/trials/walking-for-recovery-from-surgery-in-improving-quality-of-life-in-older-adults-with-lung-or-gastrointestinal-cancer-and-45281 https://curecurrent.com/trials/a-single-arm-multicenter-prospective-clinical-study-of-adebrelimab-combined-with-apatinib-neoadjuvant-therapy-for-resect-45282 https://curecurrent.com/trials/prophylaxis-for-patients-at-risk-of-covid-19-infection-v-45283 https://curecurrent.com/trials/radical-resection-with-contralateral-lymph-node-dissection-for-clinical-n3-nsclc-45284 https://curecurrent.com/trials/dzd9008-in-combination-with-bevacizumab-in-locally-advanced-or-metastatic-nsclc-patients-with-egfr-mutation-wu-kong29-45285 https://curecurrent.com/trials/international-registry-of-congenital-portosystemic-shunt-ircpss-45286 https://curecurrent.com/trials/first-line-treatment-of-participants-with-stage-iv-squamous-non-small-cell-lung-cancer-with-necitumumab-and-gemcitabine-45287 https://curecurrent.com/trials/a-multi-omics-sequencing-based-model-for-predicting-efficacy-and-dynamic-monitoring-of-treatment-in-small-cell-lung-canc-45288 https://curecurrent.com/trials/a-study-of-mhb088c-injection-versus-treatment-of-physician-s-choice-in-subjects-with-relapsed-small-cell-lung-cancer-45289 https://curecurrent.com/trials/clinical-application-study-of-pet-ct-for-differential-diagnosis-of-non-small-cell-lung-cancer-45290 https://curecurrent.com/trials/phase-ib-first-in-human-dose-escalation-of-gt103-in-refractory-advanced-stage-non-small-cell-lung-cancer-top-1902-45291 https://curecurrent.com/trials/randomized-study-of-carbon-ion-boost-in-hypoxic-lesions-for-locally-advanced-non-small-cell-lung-cancer-45292 https://curecurrent.com/trials/spatial-fragmentation-combined-with-low-dose-radiotherapy-for-immunotherapy-combined-with-chemotherapy-resistant-locally-45293 https://curecurrent.com/trials/tubeless-anesthesia-in-preventing-lung-complications-in-patients-undergoing-surgery-for-early-stage-lung-cancer-45294 https://curecurrent.com/trials/postoperative-telerehabilitation-in-older-adults-45295 https://curecurrent.com/trials/long-term-outcomes-among-patients-with-programmed-death-ligand-1-1-metastatic-non-small-cell-lung-cancer-treated-with-fi-45296 https://curecurrent.com/trials/switch-maintenance-pembrolizumab-in-patients-with-nsclc-after-first-line-platinum-doublet-chemotherapy-45297 https://curecurrent.com/trials/feasibility-study-of-tissue-and-blood-collection-in-oncogene-addicted-and-neoadjuvantly-treated-non-small-cell-lung-canc-45298 https://curecurrent.com/trials/ga-dpa-in-the-lung-cancer-diagnosis-45299 https://curecurrent.com/trials/platform-trial-of-novel-regimens-versus-standard-of-care-soc-in-participants-with-non-small-cell-lung-cancer-nsclc-45300 https://curecurrent.com/trials/a-study-of-cdx-585-in-patients-with-advanced-malignancies-45301 https://curecurrent.com/trials/sintilimab-plus-anlotinib-as-second-or-further-line-therapy-for-es-sclc-who-have-progressed-after-anti-pd-1-l1-therapy-45302 https://curecurrent.com/trials/reducing-chronic-breathlessness-in-adults-by-following-a-self-guided-internet-based-supportive-intervention-self-breathe-45303 https://curecurrent.com/trials/immunotherapy-with-or-without-sbrt-in-patients-with-stage-iv-non-small-cell-lung-cancer-45304 https://curecurrent.com/trials/carbon-ion-therapy-for-peripheral-non-small-cell-lung-cancer-45305 https://curecurrent.com/trials/pre-approval-access-with-amivantamab-jnj-61186372-in-participants-with-metastatic-non-small-cell-lung-cancer-45306 https://curecurrent.com/trials/national-project-on-vaccines-covid-19-and-frail-patients-45307 https://curecurrent.com/trials/improving-pharmacological-transition-of-palliative-care-patients-from-inpatient-to-outpatient-care-45308 https://curecurrent.com/trials/carbon-ion-radiotherapy-for-locally-advanced-lung-cancer-in-elderly-patients-45309 https://curecurrent.com/trials/testing-the-effects-of-mk-3475-pembrolizumab-with-or-without-the-usual-chemotherapy-treatment-for-patients-70-years-of-a-45310 https://curecurrent.com/trials/dose-escalated-adaptive-radiotherapy-of-thoracic-disease-for-small-cell-lung-cancer-45311 https://curecurrent.com/trials/hypofractionated-boost-before-chemoradiation-for-patients-with-stage-ii-iii-non-small-cell-lung-cancer-unsuitable-for-su-45312 https://curecurrent.com/trials/effect-of-rapid-rollover-on-pneumothorax-after-ct-guided-lung-biopsy-45313 https://curecurrent.com/trials/phase-2-study-of-dacomitinib-in-nsclc-45314 https://curecurrent.com/trials/a-pan-asian-clinical-database-of-egfr-exon-20-insertion-mutated-nsclc-45315 https://curecurrent.com/trials/neoadjuvant-wx-0593-in-resectable-alk-positive-or-ros1-positive-non-small-cell-lung-cancer-45316 https://curecurrent.com/trials/sbrt-followed-by-neoadjuvant-immunochemotherapy-in-resectable-stage-ii-to-iii-non-small-cell-lung-cancer-45317 https://curecurrent.com/trials/d-bace-in-combination-with-chemotherapy-and-carelizumab-for-resectable-ii-iiia-or-potentially-resectable-t3-4n2-stage-ii-45318 https://curecurrent.com/trials/pulmonary-resection-and-intensive-rehabilitation-45319 https://curecurrent.com/trials/study-of-lorlatinib-in-people-with-alk-positive-non-small-cell-lung-cancer-45320 https://curecurrent.com/trials/pei-regimen-a-therapeutic-option-in-small-cell-lung-cancer-a-monoinstitutional-experience-of-46-consecutive-cases-45321 https://curecurrent.com/trials/rarecells-molecular-biomarkers-for-early-detection-of-lung-cancer-45322 https://curecurrent.com/trials/phase-2-dacomitinib-study-on-patients-with-egfr-driven-advanced-solid-tumours-with-low-egfr-as1-incrna-expr-or-other-nov-45323 https://curecurrent.com/trials/toward-high-fidelity-adaptive-radiotherapy-in-the-thorax-45324 https://curecurrent.com/trials/a-study-of-neoadjuvant-adjuvant-durvalumab-for-the-treatment-of-patients-with-resectable-non-small-cell-lung-cancer-45325 https://curecurrent.com/trials/a-study-to-evaluate-efficacy-and-safety-of-ql2107-plus-chemo-and-compare-with-keytruda-in-participants-with-iv-nqnsclc-45326 https://curecurrent.com/trials/dna-methylation-biomarkers-to-predict-survival-after-surgery-for-lung-adenocarcinoma-45327 https://curecurrent.com/trials/pd-1-combined-with-bevacizumab-and-pcsk-9-inhibitor-in-patients-with-advanced-nsclc-who-have-progressed-after-anti-pd-1-45328 https://curecurrent.com/trials/a-study-of-egf816-and-gefitinib-in-tki-na-ve-egfr-mutant-non-small-cell-lung-cancer-45329 https://curecurrent.com/trials/validation-of-a-multi-gene-test-for-lung-cancer-risk-45330 https://curecurrent.com/trials/postoperative-egfr-tki-therapy-forcontralateral-pulmonary-nodules-in-patients-with-egfr-mutant-nsclc-armor2501-45331 https://curecurrent.com/trials/ai-driven-precision-diagnostic-system-for-lung-cancer-based-on-liquid-biopsy-45332 https://curecurrent.com/trials/efficacy-and-biomarkers-of-the-second-line-treatment-of-adebelizumab-combined-with-irinotecan-liposome-in-advanced-small-45333 https://curecurrent.com/trials/the-safety-and-feasibility-of-costal-bone-marrow-aspiration-during-thoracic-surgery-45334 https://curecurrent.com/trials/trilaciclib-in-combination-with-docetaxel-for-second-line-and-beyond-treatment-of-locally-advanced-or-metastatic-nsclc-45335 https://curecurrent.com/trials/medical-access-program-for-patritumab-deruxtecan-45336 https://curecurrent.com/trials/phase-ii-study-of-platinum-cisplatin-carboplatin-and-polymeric-micelles-paclitaxel-pm-pac-with-ivonescimab-in-first-line-45337 https://curecurrent.com/trials/comparison-of-spect-ct-perfusion-and-volumetric-ct-volume-45338 https://curecurrent.com/trials/tusamitamab-ravtansine-sar408701-in-combination-with-ramucirumab-or-ramucirumab-and-pembrolizumab-in-pretreated-patients-45339 https://curecurrent.com/trials/omitting-ctv-for-primary-tumor-in-ls-sclc-45340 https://curecurrent.com/trials/two-schedules-of-hyperfractionated-thoracic-radiotherapy-in-limited-disease-small-cell-lung-cancer-45341 https://curecurrent.com/trials/phase-1-2-study-of-bbt-176-in-advanced-nsclc-with-progression-after-egfr-tki-treatment-45342 https://curecurrent.com/trials/engineering-evaluation-of-the-helix-ventilator-45343 https://curecurrent.com/trials/a-study-on-the-efficacy-and-safety-of-golidocitinib-combined-with-tislelizumab-and-chemotherapy-as-first-line-treatment-45344 https://curecurrent.com/trials/pembrolizumab-after-radiation-therapy-and-chemotherapy-in-limited-stage-small-cell-lung-cancer-45345 https://curecurrent.com/trials/a-pilot-study-to-explore-the-role-of-gut-flora-in-metastatic-mesothelioma-45346 https://curecurrent.com/trials/interventional-ablation-for-early-stage-lung-cancer-45347 https://curecurrent.com/trials/factors-determine-the-feasibility-and-surgical-margin-quality-of-sublobar-resection-for-non-small-cell-lung-cancer-45348 https://curecurrent.com/trials/ai-based-ultrasound-prediction-model-for-intracranial-pressure-and-prognosis-in-lung-cancer-patients-with-leptomeningeal-45349 https://curecurrent.com/trials/complementary-treatment-of-pg2-to-improve-clinical-benefit-response-and-quality-of-life-in-fatigue-45350 https://curecurrent.com/trials/tunisian-lung-cancer-study-45351 https://curecurrent.com/trials/comparison-of-continuous-esp-versus-tea-after-thoracotomy-45352 https://curecurrent.com/trials/comparison-paravertebral-and-serratus-anterior-plane-block-in-video-assisted-thoracoscopic-surgery-45353 https://curecurrent.com/trials/lurbinectedin-pm01183-combined-with-pembrolizumab-in-small-cell-lung-cancer-45354 https://curecurrent.com/trials/platform-trial-of-novel-regimens-versus-standard-of-care-soc-in-participants-with-non-small-cell-lung-cancer-nsclc-sub-s-45355 https://curecurrent.com/trials/clinical-study-on-chimeric-antigen-receptor-t-lymphocyte-car-t-targeting-cea-for-the-treatment-of-cea-positive-advanced-45356 https://curecurrent.com/trials/ak129-combination-therapy-for-advanced-solid-tumors-45357 https://curecurrent.com/trials/real-world-utilization-and-outcomes-with-dacomitinib-first-line-treatment-for-egfr-mutation-positive-advanced-non-small-45358 https://curecurrent.com/trials/a-trial-to-compare-the-efficacy-safety-pharmacokinetics-and-immunogenicity-of-hd204-to-avastin-in-advanced-non-squamous-45359 https://curecurrent.com/trials/first-line-sintilimab-combined-with-anlotinib-and-platinum-doublet-chemotherapy-in-malignant-pleural-mesothelioma-45360 https://curecurrent.com/trials/neoadjuvant-durvalumab-and-chemotherapy-followed-by-surgery-crt-and-durvalumab-in-borderline-resectable-stage-iii-nsclc-45361 https://curecurrent.com/trials/lung-cancer-screening-eligibility-assessment-45362 https://curecurrent.com/trials/phase-1-2-study-of-the-highly-selective-ret-inhibitor-pralsetinib-blu-667-in-participants-with-thyroid-cancer-non-small-45363 https://curecurrent.com/trials/early-intervention-strategies-for-lung-cancer-45364 https://curecurrent.com/trials/pembrolizumab-plus-chemotherapy-in-nsclc-with-targetable-genetic-alterations-after-progression-on-targeted-agents-45365 https://curecurrent.com/trials/ds-8201a-in-human-epidermal-growth-factor-receptor-2-her2-expressing-or-mutated-non-small-cell-lung-cancer-45366 https://curecurrent.com/trials/liquid-biopsy-lung-and-colon-cancer-in-andalucia-45367 https://curecurrent.com/trials/the-effect-of-pranayama-breathing-exercise-on-quality-of-life-in-lung-cancer-patients-45368 https://curecurrent.com/trials/stereotactic-body-radiotherapy-followed-by-tislelizumab-plus-platinum-based-chemotherapy-versus-tislelizumab-plus-platin-45369 https://curecurrent.com/trials/evaluating-safety-and-biomarkers-using-dk210-egfr-for-locally-advanced-or-metastatic-egfr-tumors-45370 https://curecurrent.com/trials/rta-408-in-the-treatment-of-advanced-solid-tumors-nsclc-melanoma-discover-45371 https://curecurrent.com/trials/safety-immunogenicity-and-preliminary-clinical-activity-study-of-pdc-lung01-cancer-vaccine-in-nsclc-45372 https://curecurrent.com/trials/study-of-ngm120-in-subjects-with-advanced-solid-tumors-pancreatic-cancer-and-prostate-cancer-using-combination-therapy-45373 https://curecurrent.com/trials/physical-activity-during-chemo-and-or-immunotherapy-for-lung-cancer-45374 https://curecurrent.com/trials/pd-l1-inhibitor-combined-with-apatinib-as-first-line-maintenance-treatment-for-extensive-stage-small-cell-lung-cancer-45375 https://curecurrent.com/trials/study-of-pf-06940434-in-patients-with-advanced-or-metastatic-solid-tumors-45376 https://curecurrent.com/trials/chemoradiation-followed-by-durvalumab-in-poor-risk-and-or-elderly-patients-with-stage-iii-nsclc-45377 https://curecurrent.com/trials/targeted-anti-cea-car-t-immunotherapy-for-advanced-lung-cancer-45378 https://curecurrent.com/trials/a-study-of-imm-6-415-in-ras-raf-mutant-solid-tumors-45379 https://curecurrent.com/trials/tocilizumab-for-prevention-of-respiratory-failure-in-patients-with-severe-covid-19-infection-45380 https://curecurrent.com/trials/nivolumab-and-ipilimumab-in-combination-with-immunogenic-chemotherapy-for-patients-with-advanced-nsclc-45381 https://curecurrent.com/trials/improving-patient-reported-outcomes-after-lung-cancer-surgery-with-mobile-internet-platform-45382 https://curecurrent.com/trials/cemiplimab-for-the-treatment-of-untreated-brain-metastases-from-pd-l1-50-non-small-cell-lung-cancer-45383 https://curecurrent.com/trials/safety-pharmacokinetics-and-preliminary-efficacy-of-cs231295-in-advanced-solid-tumors-45384 https://curecurrent.com/trials/risk-stratification-for-patients-with-hospital-diagnosed-advanced-lung-cancer-45385 https://curecurrent.com/trials/a-digital-therapeutic-solution-for-cancer-patients-45386 https://curecurrent.com/trials/prophet-study-ctdna-guided-personalized-induction-immunochemotherapy-for-nsclc-45387 https://curecurrent.com/trials/gene-molecular-alterations-as-disease-prognostic-markers-in-patients-with-non-small-cell-lung-cancer-nsclc-45388 https://curecurrent.com/trials/a-culturally-based-palliative-care-tele-consult-program-for-rural-southern-elders-45389 https://curecurrent.com/trials/study-of-durvalumab-in-combination-with-platinum-and-etoposide-for-the-first-line-treatment-of-patients-with-extensive-s-45390 https://curecurrent.com/trials/chemotherapy-radiotherapy-versus-concomitant-chemotherapy-followed-by-radiotherapy-in-stage-iiib-non-small-cell-lung-can-45391 https://curecurrent.com/trials/trial-of-nanopac-intratumoral-injection-in-lung-cancer-45392 https://curecurrent.com/trials/a-rct-on-the-preventive-effect-of-hfnc-on-postoperative-pulmonary-complications-in-patients-with-gynecologic-neoplasms-45393 https://curecurrent.com/trials/association-of-psychological-distress-in-patients-with-lung-cancer-45394 https://curecurrent.com/trials/anti-interleukin-8-anti-il-8-for-patients-with-covid-19-45395 https://curecurrent.com/trials/supporting-parents-to-choose-wisely-45396 https://curecurrent.com/trials/exercise-training-and-behavioral-modification-for-the-improvement-of-physical-activity-in-head-and-neck-cancer-patients-45397 https://curecurrent.com/trials/analysis-of-drug-resistance-in-immune-checkpoint-inhibitors-of-non-small-cell-lung-cancer-45398 https://curecurrent.com/trials/molecular-landscape-analysis-and-clinical-implications-for-nsclc-patients-with-rare-mutations-45399 https://curecurrent.com/trials/a-study-of-the-effects-of-alks-4230-nemvaleukin-alfa-on-subjects-with-solid-tumors-45400 https://curecurrent.com/trials/pembrolizumab-and-trametinib-in-treating-patients-with-stage-iv-non-small-cell-lung-cancer-and-kras-gene-mutations-45401 https://curecurrent.com/trials/vebreltinib-plus-plb1004-in-egfr-mutated-advanced-nsclc-with-met-amplification-or-met-overexpression-following-egfr-tki-45402 https://curecurrent.com/trials/a-clinical-study-on-the-efficacy-and-safety-of-the-combination-of-limertinib-and-bevacizumab-versus-limertinib-as-first-45403 https://curecurrent.com/trials/vebreltinib-plus-plb1004-as-the-first-line-therapy-for-patients-with-egfrm-met-locally-advanced-or-metastatic-nsclc-45404 https://curecurrent.com/trials/rucaparib-in-treating-patients-with-genomic-loh-high-and-or-deleterious-brca1-2-mutation-stage-iv-or-recurrent-non-small-45405 https://curecurrent.com/trials/vebreltinib-plus-plb1004-versus-platinum-based-doublet-chemotherapy-in-patients-with-egfrm-met-locally-advanced-or-metas-45406 https://curecurrent.com/trials/trial-of-ctdna-of-guidance-to-determine-postoperative-radiation-therapy-45407 https://curecurrent.com/trials/proactive-outreach-and-shared-decision-making-in-improving-lung-cancer-screening-rates-in-primary-care-patients-45408 https://curecurrent.com/trials/maintenance-durvalumab-medi4736-and-olaparib-azd2281-after-standard-1st-line-treatment-carboplatin-cisplatin-etoposide-d-45409 https://curecurrent.com/trials/improving-lung-cancer-screening-adherence-by-overcoming-barriers-for-vulnerable-populations-45410 https://curecurrent.com/trials/apixaban-in-preventing-secondary-cancer-related-venous-thrombosis-in-cancer-patients-who-have-completed-anticoagulation-45411 https://curecurrent.com/trials/tgrx-326-chinese-phase-iii-for-advanced-non-small-cell-lung-cancer-nsclc-45412 https://curecurrent.com/trials/tgrx-326-pharmacokinetic-food-effect-bioavailability-study-45413 https://curecurrent.com/trials/perioperative-tislelizumab-for-resectable-ii-iiib-n2-kras-mutated-nonsquamous-non-small-cell-lung-cancer-45414 https://curecurrent.com/trials/this-is-a-two-cohort-exploratory-clinical-study-assessing-the-activity-of-benmelstobart-combined-with-chemotherapy-with-45415 https://curecurrent.com/trials/tgrx-326-chinese-phase-i-for-advanced-non-small-cell-lung-cancer-nsclc-45416 https://curecurrent.com/trials/predicting-non-small-cell-lung-cancer-nsclc-lymph-node-metastasis-integrating-circulating-tumor-dna-ctdna-mutation-methy-45417 https://curecurrent.com/trials/tgrx-326-chinese-phase-ii-for-advanced-non-small-cell-lung-cancer-nsclc-45418 https://curecurrent.com/trials/study-of-capmatinib-efficacy-in-comparison-with-docetaxel-in-previously-treated-participants-with-non-small-cell-lung-ca-45419 https://curecurrent.com/trials/application-of-extended-reality-xr-assisted-ct-guided-localization-of-pulmonary-nodules-in-thoracoscopic-sublobar-resect-45420 https://curecurrent.com/trials/study-of-th-302-or-placebo-in-combination-with-pemetrexed-in-patients-with-non-squamous-non-small-cell-lung-cancer-45421 https://curecurrent.com/trials/chemoembolization-for-lung-tumors-45422 https://curecurrent.com/trials/early-integrated-telehealth-versus-in-person-palliative-care-for-patients-with-lung-cancer-45423 https://curecurrent.com/trials/the-associations-of-sleep-disturbance-with-therapy-efficacy-and-prognosis-of-lung-cancer-45424 https://curecurrent.com/trials/a-phase-1-2-study-to-evaluate-the-safety-tolerability-and-pk-of-jin-a02-in-patients-with-egfr-mutant-advanced-nsclc-45425 https://curecurrent.com/trials/trial-of-trametinib-and-ponatinib-in-patients-with-kras-mutant-advanced-non-small-cell-lung-cancer-45426 https://curecurrent.com/trials/a-study-of-hydroxycholoroquine-compared-to-placebo-as-treatment-for-people-with-covid-19-45427 https://curecurrent.com/trials/clinical-study-of-combined-epha2-targeted-car-dc-and-car-t-cell-therapy-for-non-small-cell-lung-cancer-45428 https://curecurrent.com/trials/pre-habilitation-in-lung-surgery-candidates-45429 https://curecurrent.com/trials/a-pilot-study-of-dacomitinib-with-or-without-osimertinib-for-patients-with-metastatic-egfr-mutant-lung-cancers-with-dise-45430 https://curecurrent.com/trials/circulating-tumor-dna-in-predicting-outcomes-in-patients-with-stage-iv-head-and-neck-cancer-or-stage-iii-iv-non-small-ce-45431 https://curecurrent.com/trials/niraparib-efficacy-in-patient-with-unresectable-mesothelioma-45432 https://curecurrent.com/trials/automated-device-for-asthma-monitoring-and-management-in-monitoring-adults-with-lung-cancer-undergoing-radiation-therapy-45433 https://curecurrent.com/trials/bovine-reinforcement-in-stomach-colorectal-and-lung-operation-45434 https://curecurrent.com/trials/radiation-therapy-and-mk-3475-for-patients-with-recurrent-metastatic-head-and-neck-cancer-renal-cell-cancer-melanoma-and-45435 https://curecurrent.com/trials/apalutamide-plus-cetrelimab-in-patients-with-treatment-emergent-small-cell-neuroendocrine-prostate-cancer-45436 https://curecurrent.com/trials/analysis-of-biopsy-specimens-to-study-responses-to-pd-1-or-pd-l1-therapies-45437 https://curecurrent.com/trials/continued-access-to-rxdx-105-45438 https://curecurrent.com/trials/exploratory-study-of-the-microbiome-of-upper-gastrointestinal-in-the-pathogenesis-of-multiple-primary-lung-cancer-45439 https://curecurrent.com/trials/bronchial-mapping-gcc-1635-45440 https://curecurrent.com/trials/survivorship-study-of-cancer-patients-who-received-cranial-radiation-therapy-45441 https://curecurrent.com/trials/mwa-with-or-without-furmonertinib-for-early-stage-non-small-cell-lung-cancer-45442 https://curecurrent.com/trials/rapa-201-therapy-of-solid-tumors-45443 https://curecurrent.com/trials/a-study-of-sys6040-for-injection-in-patients-with-advanced-solid-tumors-45444 https://curecurrent.com/trials/study-of-irx4204-with-erlotinib-in-previously-treated-advanced-nsclc-45445 https://curecurrent.com/trials/high-dose-firmonertinib-combined-with-bevacizumab-and-intrathecal-pemetrexed-in-the-treatment-of-egfr-mutated-non-small-45446 https://curecurrent.com/trials/navigation-endobronchial-ultrasound-45447 https://curecurrent.com/trials/a-novel-method-for-treating-lung-met-w-combo-of-electric-fields-rad-therapy-a-single-arm-45448 https://curecurrent.com/trials/piloting-mpal-a-multilevel-strategy-for-palliative-care-implementation-45449 https://curecurrent.com/trials/phase-1-2-study-of-apr-246-in-combination-with-pembrolizumab-in-subjects-with-solid-tumor-malignancies-45450 https://curecurrent.com/trials/a-phase-i-study-to-evaluate-the-safety-pharmacokinetics-and-antitumor-activity-of-hc010-in-patients-with-advanced-solid-45451 https://curecurrent.com/trials/efficacy-of-torque-teno-virus-as-a-biomarker-for-predicting-treatment-response-of-immune-checkpoint-inhibitor-therapy-an-45452 https://curecurrent.com/trials/phase-i-ii-trial-of-alectinib-and-bevacizumab-in-patients-with-advanced-anaplastic-lymphoma-kinase-alk-positive-non-smal-45453 https://curecurrent.com/trials/tislelizumab-in-cancer-patients-with-molecular-residual-disease-45454 https://curecurrent.com/trials/using-a-targeted-cancer-vaccine-galinpepimut-s-with-immunotherapy-nivolumab-in-mesothelioma-45455 https://curecurrent.com/trials/nad-supplement-nmn-with-radioimmunotherapy-in-advanced-nsclc-45456 https://curecurrent.com/trials/to-evaluate-the-efficacy-and-safety-of-anlotinib-combined-with-furmonertinib-mesylate-in-lung-cancer-45457 https://curecurrent.com/trials/tetracycline-as-a-prophylaxis-for-rash-in-patients-with-nsclc-receiving-treatment-with-bibw2992-afatinib-45458 https://curecurrent.com/trials/a-study-of-sea-cd40-given-with-other-drugs-in-cancers-45459 https://curecurrent.com/trials/cutting-edge-imaging-technologies-to-improve-the-safety-and-the-sustainability-of-lung-cancer-screening-and-the-accuracy-45460 https://curecurrent.com/trials/low-flow-vs-high-flow-nasal-cannula-for-hypoxemic-immunocompromised-patients-during-diagnostic-bronchoscopy-45461 https://curecurrent.com/trials/m7824-and-topotecan-or-temozolomide-in-relapsed-small-cell-lung-cancers-45462 https://curecurrent.com/trials/optimizing-post-thoracotomy-pain-management-comparing-erector-spinae-vs-paravertebral-block-in-thoracotomy-patients-45463 https://curecurrent.com/trials/impact-of-psychological-stress-on-treatment-response-and-prognosis-in-lung-cancer-patients-45464 https://curecurrent.com/trials/pembrolizumab-with-standard-cytotoxic-chemotherapy-in-treatment-naive-nsclc-patients-with-asymptomatic-brain-metastases-45465 https://curecurrent.com/trials/novel-epigenetic-mapping-in-cell-free-dna-for-the-detection-of-lung-cancer-45466 https://curecurrent.com/trials/a-phase-ib-study-of-hs-10370-in-addition-to-other-anti-cancer-therapies-in-patients-with-advanced-solid-tumors-45467 https://curecurrent.com/trials/surufatinib-in-combination-with-tislelizumab-in-subjects-with-advanced-solid-tumors-45468 https://curecurrent.com/trials/sotorasib-in-previously-treated-locally-advanced-or-metastatic-nsclc-subjects-with-mutated-kras-p-g12c-45469 https://curecurrent.com/trials/the-efficacy-and-safety-of-sintilimab-plus-chemotherapy-in-surgical-conversion-for-patients-with-unresectable-stage-iiib-45470 https://curecurrent.com/trials/real-world-assessment-of-therapeutic-strategies-and-survival-outcomes-following-first-line-tislelizumab-therapy-in-advan-45471 https://curecurrent.com/trials/a-trial-of-durvalumab-and-tremelimumab-in-combination-with-sbrt-in-patients-with-metastatic-cancer-45472 https://curecurrent.com/trials/nano-crystalline-megestrol-acetate-combined-with-standard-treatment-versus-standard-treatment-for-first-line-extensive-s-45473 https://curecurrent.com/trials/clinical-study-on-nanocrystalline-megestrol-acetate-for-appetite-improvement-and-weight-gain-in-pre-cachexia-and-cachexi-45474 https://curecurrent.com/trials/armstrong-air-entrainment-vs-standard-treatment-in-non-expandable-lung-45475 https://curecurrent.com/trials/a-study-of-bl-b01d1-in-combination-with-osimertinib-mesylate-tablets-in-patients-with-locally-advanced-or-metastatic-non-45476 https://curecurrent.com/trials/sacituzumab-govitecan-and-bevacizumab-for-nsclc-brain-metastases-45477 https://curecurrent.com/trials/retrospective-clinical-trial-comparing-radiologists-diagnosis-accuracy-in-lung-cancer-screening-population-with-and-with-45478 https://curecurrent.com/trials/prophylactic-peg-rhg-csf-during-ccrt-in-la-nsclc-45479 https://curecurrent.com/trials/combining-electrical-impedance-tomography-and-thoracic-ultrasound-toinvestigate-dynamic-changes-45480 https://curecurrent.com/trials/umbrella-trial-of-adjuvant-therapy-in-completely-resected-high-risk-stage-ia-ib-nsclc-focus-on-driver-mutations-45481 https://curecurrent.com/trials/danvatirsen-and-durvalumab-in-treating-patients-with-advanced-and-refractory-pancreatic-non-small-cell-lung-cancer-and-m-45482 https://curecurrent.com/trials/olaparib-in-patients-with-hrd-malignant-mesothelioma-45483 https://curecurrent.com/trials/a-phase-i-ib-study-of-niz985-alone-and-in-combination-with-spartalizumab-45484 https://curecurrent.com/trials/organoid-guided-personalized-treatment-of-pleural-effusion-45485 https://curecurrent.com/trials/building-engagement-using-financial-incentives-trial-colorectal-cancer-screening-45486 https://curecurrent.com/trials/lung-cancer-exercise-training-study-45487 https://curecurrent.com/trials/zd1839-with-hypofractionated-radiation-therapy-with-an-immobilization-device-for-advanced-non-small-cell-lung-cancer-45488 https://curecurrent.com/trials/alimta-carboplatin-and-radiation-therapy-for-non-small-cell-lung-cancer-45489 https://curecurrent.com/trials/source-lung-stereotactic-ablative-radiation-therapy-of-ultracentral-lung-tumours-source-lung-45490 https://curecurrent.com/trials/ak112-in-combination-with-chemotherapy-in-advanced-squamous-non-small-cell-lung-cancer-45491 https://curecurrent.com/trials/a-prospective-study-the-impact-of-sleep-disturbances-on-immunotherapy-in-patients-with-lung-cancer-45492 https://curecurrent.com/trials/vic-1911-monotherapy-in-combination-with-sotorasib-for-the-treatment-of-kras-g12c-mutant-non-small-cell-lung-cancer-45493 https://curecurrent.com/trials/feasibility-of-bright-light-therapy-on-fatigue-sleep-and-circadian-activity-rhythms-in-lung-cancer-survivors-45494 https://curecurrent.com/trials/immunonutrition-for-improving-the-efficacy-of-immunotherapy-in-patients-with-metastatic-non-small-cell-lung-cancer-45495 https://curecurrent.com/trials/sleep-state-in-lung-cancer-a-retrospective-analysis-45496 https://curecurrent.com/trials/prognostic-correlation-between-the-ratio-of-the-neutrophil-ratio-to-the-ratio-of-cd4-cd8-t-cells-in-patients-with-advanc-45497 https://curecurrent.com/trials/study-to-evaluate-safety-and-pk-of-chs-006-in-combination-with-toripalimab-in-patients-with-advanced-solid-tumors-45498 https://curecurrent.com/trials/prospective-single-arm-phase-ii-clinical-study-of-irinotecan-hydrochloride-liposome-injection-combined-with-platinum-and-45499 https://curecurrent.com/trials/induction-chemo-nivo-in-unresectable-stage-iii-nsclc-45500 https://curecurrent.com/trials/comparison-of-three-different-puncture-techniques-in-ebus-tbna-45501 https://curecurrent.com/trials/in10018-combination-therapy-in-treatment-na-ve-es-sclc-45502 https://curecurrent.com/trials/a-study-of-erlotinib-plus-radiotherapy-rt-for-patients-with-advanced-or-inoperable-non-small-cell-lung-cancer-45503 https://curecurrent.com/trials/sbrt-for-oligo-residual-nsclc-after-treatment-with-pd-1-pd-l1-immune-checkpoint-inhibitors-45504 https://curecurrent.com/trials/multiomics-tumor-evolution-model-of-nsclc-45505 https://curecurrent.com/trials/prognostic-value-of-tumor-hypoxia-as-measured-by-18f-fmiso-breath-hold-pet-ct-in-non-small-cell-lung-cancer-nsclc-patien-45506 https://curecurrent.com/trials/midrixneo-lung-dendritic-cell-vaccine-in-patients-with-non-small-cell-lung-cancer-45507 https://curecurrent.com/trials/a-study-of-zenocutuzumab-mcla-128-in-patients-with-solid-tumors-harboring-an-nrg1-fusion-enrgy-45508 https://curecurrent.com/trials/a-study-of-lazertinib-in-participants-with-epidermal-growth-factor-receptor-egfr-mutation-positive-advanced-non-small-ce-45509 https://curecurrent.com/trials/decision-counseling-program-in-increasing-shared-decision-making-and-clinical-trial-participation-in-patients-with-stage-45510 https://curecurrent.com/trials/car-t-cells-in-mesothelin-expressing-cancers-45511 https://curecurrent.com/trials/srk-181-alone-or-in-combination-with-anti-pd-l-1-antibody-therapy-in-patients-with-locally-advanced-or-metastatic-solid-45512 https://curecurrent.com/trials/autologous-dendritic-cell-vaccination-in-mesothelioma-45513 https://curecurrent.com/trials/genetics-and-shared-decision-making-in-improving-care-for-patients-with-stage-iva-c-non-small-cell-lung-cancer-45514 https://curecurrent.com/trials/first-local-anaesthesia-thoracoscopy-for-pleural-effusion-diagnosis-45515 https://curecurrent.com/trials/a-real-world-study-on-the-treatment-of-non-small-cell-lung-cancer-with-leptomeningeal-metastasis-in-china-45516 https://curecurrent.com/trials/second-line-regimen-combined-with-radiotherapy-versus-without-radiotherapy-in-patients-with-locally-advanced-oligometast-45517 https://curecurrent.com/trials/a-study-to-evaluate-the-clinical-efficacy-of-jnj-42756493-erdafitinib-a-pan-fibroblast-growth-factor-receptor-fgfr-tyros-45518 https://curecurrent.com/trials/first-in-human-study-of-bbt-207-in-advanced-non-small-cell-lung-cancer-harboring-egfr-mutation-after-treatment-with-egfr-45519 https://curecurrent.com/trials/comparison-of-neoadjuvant-cadonilimab-versus-chemotherapy-combined-with-pd-1-in-the-treatment-of-resectable-non-small-ce-45520 https://curecurrent.com/trials/dbt-for-metastatic-lung-cancer-45522 https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-efficacy-of-a2b530-a-logic-gated-car-t-in-participants-with-solid-tumors-that-express-45523 https://curecurrent.com/trials/hypofractionated-radiotherapy-followed-by-chemo-immunotherapy-induction-therapy-45524 https://curecurrent.com/trials/adagrasib-in-combination-with-nab-sirolimus-in-patients-with-advanced-solid-tumors-and-non-small-cell-lung-cancer-with-a-45525 https://curecurrent.com/trials/descriptive-study-of-the-incidence-of-malignancy-in-severe-asthma-patients-receiving-benralizumab-and-other-biologic-the-45526 https://curecurrent.com/trials/confirmation-of-accuracy-of-the-tool-in-lesion-technology-tilt-of-the-galaxy-system-with-integrated-tomo-technology-45527 https://curecurrent.com/trials/sleep-disorders-and-tumor-immune-microenvironment-45528 https://curecurrent.com/trials/brigatinib-plus-chemotherapy-or-local-consolidation-therapy-in-alk-positive-advanced-non-small-cell-lung-cancer-brightst-45529 https://curecurrent.com/trials/bronchoscopic-cryo-immunotherapy-of-lung-cancer-45530 https://curecurrent.com/trials/exploration-of-risk-factors-for-postoperative-cerebral-infarction-in-lung-cancer-patients-a-retrospective-single-centre-45531 https://curecurrent.com/trials/the-effects-of-a-family-centered-tai-chi-exercise-on-lung-function-and-mental-health-of-patients-after-thoracoscopic-sur-45532 https://curecurrent.com/trials/a-study-of-sapanisertib-in-relapsed-refractory-nfe2l2-mutated-and-wild-type-squamous-non-small-cell-lung-cancer-45533 https://curecurrent.com/trials/evaluate-safety-and-tolerability-of-rx001-in-patients-with-kras-mutant-advanced-nsclc-45534 https://curecurrent.com/trials/benmelstobart-anlotinib-and-chemotherapy-as-first-line-treatment-for-extensive-stage-small-cell-lung-cancer-45535 https://curecurrent.com/trials/ef-36-keynote-b36-a-pilot-randomized-open-label-study-of-tumor-treating-fields-ttfields-150-khz-concomitant-with-pembrol-45536 https://curecurrent.com/trials/bispecific-psmaxcd3-antibody-cc-1-in-patients-with-squamous-cell-carcinoma-of-the-lung-45537 https://curecurrent.com/trials/a-study-of-the-oral-egfr-inhibitor-plb1004-in-non-small-cell-lung-cancer-45538 https://curecurrent.com/trials/18f-labeled-fap-targeted-molecular-probe-in-early-tumor-diagnosis-45539 https://curecurrent.com/trials/cryoablation-combined-with-tislelizumab-and-chemotherapy-as-neoadjuvant-and-adjuvant-therapy-in-resectable-stage-ii-iiib-45540 https://curecurrent.com/trials/project-plus-lung-cancer-screening-promotion-45541 https://curecurrent.com/trials/prehabilitation-for-patients-undergoing-lung-cancer-surgery-45542 https://curecurrent.com/trials/telehealth-based-synchronous-navigation-to-improve-molecularly-informed-care-for-patients-with-lung-cancer-45543 https://curecurrent.com/trials/neoadjuvant-nivolumab-plus-ipilimumab-in-resectable-nsclc-galaxy-3-45544 https://curecurrent.com/trials/a-multicenter-single-arm-phase-ii-study-to-evaluate-the-efficacy-and-safety-of-fulzerasib-ibi351-in-combination-with-ivo-45545 https://curecurrent.com/trials/comparison-of-40-glucose-solution-and-autologous-blood-patch-pleurodesis-for-postoperative-air-leak-after-lung-resection-45546 https://curecurrent.com/trials/a-safety-and-efficacy-study-of-cc-90011-in-participants-with-relapsed-and-or-refractory-solid-tumors-and-non-hodgkin-s-l-45547 https://curecurrent.com/trials/study-of-efficacy-and-safety-of-cml-cp-patients-treated-with-asciminib-versus-best-available-therapy-previously-treated-45548 https://curecurrent.com/trials/temple-health-chest-initiative-thci-2-0-45549 https://curecurrent.com/trials/comparing-btva-and-mwa-in-copd-with-early-lung-cancer-efficacy-and-safety-45550 https://curecurrent.com/trials/study-of-an-anti-her3-antibody-hmbd-001-with-or-without-chemotherapy-in-patients-with-solid-tumors-harboring-an-nrg1-fus-45551 https://curecurrent.com/trials/hippocampus-avoidance-whole-brain-radiation-therapy-with-simultaneous-integrated-boost-for-bms-of-nsclc-45552 https://curecurrent.com/trials/a-study-of-shr-1826-for-injection-in-combination-with-other-antitumor-therapies-in-subjects-with-nsclc-45553 https://curecurrent.com/trials/local-consolidative-radiotherapy-for-oligoprogressive-in-non-small-cell-lung-carcinoma-45554 https://curecurrent.com/trials/sitravatinib-plus-pembrolizumab-in-patients-with-advanced-treatment-na-ve-pd-l1-non-squamous-nsclc-45555 https://curecurrent.com/trials/a-study-to-evaluate-subcutaneous-durvalumab-in-patients-with-non-small-cell-lung-cancer-and-small-cell-lung-cancer-45556 https://curecurrent.com/trials/study-to-evaluate-the-efficacy-and-safety-of-nintedanib-bibf-1120-prednisone-taper-in-patients-with-radiation-pneumoniti-45557 https://curecurrent.com/trials/a-study-of-bms-986315-and-nivolumab-in-combination-with-chemotherapy-in-participants-with-first-line-stage-iv-or-recurre-45558 https://curecurrent.com/trials/liquid-biopsy-based-novel-modality-for-postoperative-management-of-lung-cancer-45559 https://curecurrent.com/trials/correlation-of-pre-and-post-operative-cancer-imaging-techniques-45560 https://curecurrent.com/trials/safety-efficacy-and-survival-outcomes-of-neoadjuvant-induction-immunotherapy-in-surgical-and-radiotherapeutic-management-45561 https://curecurrent.com/trials/a-trial-of-an0025-with-chemoradiation-therapy-in-stage-iii-nsclc-participants-45562 https://curecurrent.com/trials/project-lung-cancer-screening-in-southern-denmark-45563 https://curecurrent.com/trials/dose-escalation-of-rmc-5552-monotherapy-in-relapsed-refractory-solid-tumors-45564 https://curecurrent.com/trials/prevention-of-gvhd-in-participants-with-hematological-malignancies-undergoing-hematopoietic-stem-cell-transplant-hsct-45565 https://curecurrent.com/trials/breath-analysis-to-diagnose-lung-cancer-45566 https://curecurrent.com/trials/a-clinical-study-of-furmonertinib-in-the-treatment-of-egfr-mutated-nsclc-with-leptomeningeal-metastases-45567 https://curecurrent.com/trials/a-study-evaluating-the-effect-of-aumolertinib-on-the-pharmacokinetics-of-midazolam-in-patients-with-nsclc-45568 https://curecurrent.com/trials/a-phase-ib-study-of-lxh254-centric-combinations-in-nsclc-or-melanoma-45569 https://curecurrent.com/trials/shr0302-combined-with-pd-1-pd-l1-inhibition-for-treatment-na-ve-or-acquired-resistant-to-immunology-nsclc-45570 https://curecurrent.com/trials/trial-of-topotecan-with-vx-970-m6620-an-atr-kinase-inhibitor-in-small-cell-cancers-and-extrapulmonary-small-cell-cancers-45571 https://curecurrent.com/trials/pilot-study-to-assess-lung-shunting-of-yttrium-90-microspheres-using-pet-ct-45572 https://curecurrent.com/trials/alflutinib-mesylate-versus-gefitinib-in-patients-with-locally-advanced-or-metastatic-non-small-cell-lung-cancer-flag-45573 https://curecurrent.com/trials/pet-ct-guided-biopsy-versus-ct-guided-biopsy-in-evaluation-of-suspected-lung-neoplasms-45574 https://curecurrent.com/trials/continuous-wireless-monitoring-of-vital-signs-and-automated-alerts-in-participants-at-home-and-during-hospitalization-45575 https://curecurrent.com/trials/an-open-label-trial-of-afatinib-giotrif-in-treatment-naive-1st-line-or-chemotherapy-pre-treated-patients-with-locally-ad-45576 https://curecurrent.com/trials/phase-1b-2a-open-label-study-of-vactosertib-in-combination-with-durvalumab-in-advanced-nsclc-45577 https://curecurrent.com/trials/xp-102-and-xp-102-in-combination-with-trametinib-in-advanced-solid-tumor-patients-with-a-braf-v600-mutation-45578 https://curecurrent.com/trials/breath-analysis-for-the-detection-of-invasive-fungal-infections-45579 https://curecurrent.com/trials/ultrasound-guided-cryobiopsy-of-mediastinal-hilar-lymph-nodes-45580 https://curecurrent.com/trials/lung-cancer-registry-45581 https://curecurrent.com/trials/statin-treatment-for-covid-19-to-optimise-neurological-recovery-45582 https://curecurrent.com/trials/development-of-the-drug-and-alcohol-respiratory-health-test-45583 https://curecurrent.com/trials/personalizing-adoptive-cell-transfer-for-solid-tumors-towards-a-new-patient-tailored-treatment-option-45584 https://curecurrent.com/trials/a2r-and-ectonucleotidases-expression-in-lung-cancer-circulating-tumor-cells-45585 https://curecurrent.com/trials/18f-fspg-pet-ct-in-diagnosing-early-lung-cancer-in-patients-with-lung-nodules-45586 https://curecurrent.com/trials/phase-ib-trial-of-hs-20117-in-combination-with-other-drugs-in-advanced-solid-tumors-45587 https://curecurrent.com/trials/a-study-of-bms-986416-with-and-without-nivolumab-in-select-solid-tumors-45588 https://curecurrent.com/trials/current-practice-of-ventilation-strategies-in-children-undergoing-general-anesthesia-45589 https://curecurrent.com/trials/real-world-experience-with-combination-chemotherapy-and-osimertinib-in-poor-prognostic-group-of-metastatic-egfr-mutated-45590 https://curecurrent.com/trials/dolce-determining-the-impact-of-optellum-s-lung-cancer-prediction-solution-45591 https://curecurrent.com/trials/m7824-versus-pembrolizumab-as-a-first-line-1l-treatment-in-participants-with-programmed-death-ligand-1-pd-l1-expressing-45592 https://curecurrent.com/trials/rafist-a-radiomics-based-tool-for-intratumoral-fibrosis-stratification-in-non-small-cell-lung-cancer-45593 https://curecurrent.com/trials/supportive-care-needs-of-bronchial-cancer-patients-in-active-treatment-a-descriptive-study-in-outpatient-oncology-45594 https://curecurrent.com/trials/telerehabilitation-in-lung-surgery-patients-45595 https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-glumetinib-combined-with-osimertinib-mesylate-versus-platinum-based-doubl-45596 https://curecurrent.com/trials/predictive-value-of-pet-ct-for-efficacy-of-neoadjuvant-immunotherapy-in-non-small-cell-lung-cancer-45597 https://curecurrent.com/trials/hemithoracic-arc-radiotherapy-post-pleural-decortication-45598 https://curecurrent.com/trials/study-of-mrtx1133-in-patients-with-advanced-solid-tumors-harboring-a-kras-g12d-mutation-45599 https://curecurrent.com/trials/does-continuous-vital-sign-monitoring-increase-investigations-and-interventions-in-complication-free-patients-45600 https://curecurrent.com/trials/patient-reported-unmet-needs-for-function-and-supportive-occupational-and-physiotherapy-rehabilitation-interventions-45601 https://curecurrent.com/trials/ab-16b5-combined-with-docetaxel-in-subjects-with-metastatic-non-small-cell-lung-cancer-egia-002-45602 https://curecurrent.com/trials/preventing-viral-pandemic-associated-risk-of-cancer-death-using-less-invasive-diagnostic-tests-liquid-biopsies-45603 https://curecurrent.com/trials/adagrasib-in-combination-with-tno155-in-patients-with-cancer-krystal-2-45604 https://curecurrent.com/trials/study-of-serplulimab-plus-chemotherapy-as-neoadjuvant-therapy-for-limited-stage-small-cell-lung-cancer-ls-sclc-45605 https://curecurrent.com/trials/feasibility-study-to-treat-lung-cancer-with-the-permanently-implantable-ldr-civasheet-45606 https://curecurrent.com/trials/efficacy-and-safety-study-of-pembrolizumab-mk-3475-with-or-without-lenvatinib-mk-7902-e7080-in-adults-with-programmed-ce-45607 https://curecurrent.com/trials/investigation-of-respiratory-related-tumour-motion-in-liver-cancer-patients-undergoing-sbrt-using-audiovisual-biofeedbac-45608 https://curecurrent.com/trials/neoadjuvant-anti-pd-1-immunotherapy-in-resectable-non-small-cell-lung-cancer-45609 https://curecurrent.com/trials/efficacy-and-safety-of-alflutinib-in-locally-advanced-or-metastatic-non-small-cell-lung-cancer-patients-with-t790m-45610 https://curecurrent.com/trials/nanocrystalline-megestrol-acetate-for-the-treatment-of-anorexia-cachexia-syndrome-in-extensive-stage-small-cell-lung-can-45611 https://curecurrent.com/trials/ast2818-in-advanced-non-small-cell-lung-cancer-with-egfr-mutations-45612 https://curecurrent.com/trials/a-phase-3-study-of-99mtc-ec-dg-spect-ct-versus-pet-ct-in-lung-cancer-45613 https://curecurrent.com/trials/quality-of-life-as-a-predictor-of-os-and-pfs-in-patients-with-lung-cancer-45614 https://curecurrent.com/trials/integrating-surgery-and-radiotherapy-following-tislelizumab-based-conversion-therapy-in-n3-stage-iii-nsclc-45615 https://curecurrent.com/trials/anti-cea-car-t-for-advanced-cea-positive-lung-carcinoma-45616 https://curecurrent.com/trials/effects-of-ba-duan-jin-for-patients-with-pulmonary-nodules-45617 https://curecurrent.com/trials/safety-tolerability-pharmacokinetics-and-anti-tumour-activity-of-alflutinib-in-advanced-non-small-cell-lung-cancer-45618 https://curecurrent.com/trials/genotyping-of-ebus-tbna-supernant-cell-free-dna-in-nsclc-45619 https://curecurrent.com/trials/glumetinib-combined-with-osimertinib-treatment-for-non-small-cell-lung-cancer-patients-45620 https://curecurrent.com/trials/sl-279252-pd1-fc-ox40l-in-subjects-with-advanced-solid-tumors-or-lymphomas-45621 https://curecurrent.com/trials/study-of-pemetrexed-platinum-chemotherapy-with-or-without-cosibelimab-in-first-line-metastatic-non-squamous-nsclc-45622 https://curecurrent.com/trials/neo-diana-neoadjuvant-treatment-for-egfr-mutated-patients-45623 https://curecurrent.com/trials/exploratory-biomarker-analysis-of-neoadjuvant-chemoimmunotherapy-followed-by-pulmonary-resection-in-stage-ii-iii-non-sma-45624 https://curecurrent.com/trials/in-vivo-egfr-molecular-classification-and-treatment-response-45625 https://curecurrent.com/trials/cprit-patient-adherence-to-lung-cancer-screening-45626 https://curecurrent.com/trials/binimetinib-and-hydroxychloroquine-in-patients-with-advanced-kras-mutant-non-small-cell-lung-cancer-45627 https://curecurrent.com/trials/lorlatinib-after-failure-of-first-line-second-generation-alk-kinase-inhibitor-in-patients-with-advanced-alk-positive-non-45628 https://curecurrent.com/trials/combined-deep-inspiration-breath-hold-dibh-expiration-planning-technique-in-patients-with-lung-tumors-in-close-proximity-45629 https://curecurrent.com/trials/nivolumab-ipilimumab-in-patients-with-advanced-refractory-pulmonary-or-gastroenteropancreatic-poorly-differentiated-neur-45630 https://curecurrent.com/trials/collection-of-sputum-and-labeling-for-lung-cancer-45631 https://curecurrent.com/trials/giessen-pulmonary-hypertension-in-lung-cancer-registry-45632 https://curecurrent.com/trials/de-escalation-immunotherapy-maintenance-duration-trial-for-stage-iv-lung-cancer-patients-with-disease-control-after-chem-45633 https://curecurrent.com/trials/description-of-the-population-with-genitourinary-tumors-and-covid-19-45634 https://curecurrent.com/trials/hypofractionated-radiation-therapy-to-improve-immunotherapy-response-in-non-small-cell-lung-cancer-45635 https://curecurrent.com/trials/sers-based-serum-molecular-spectral-screening-for-benign-and-malignant-pulmonary-proliferative-nodules-45636 https://curecurrent.com/trials/sers-based-serum-molecular-spectral-screening-for-hematogenous-metastasis-45637 https://curecurrent.com/trials/sers-based-serum-molecular-spectral-detection-of-invasive-lung-cancer-45638 https://curecurrent.com/trials/molecular-imaging-of-fap-expressing-cancer-associated-fibroblasts-in-nsclc-treated-with-immune-checkpoint-inhibitors-45639 https://curecurrent.com/trials/sers-based-serum-molecular-spectral-screening-for-lung-cancer-type-45640 https://curecurrent.com/trials/sers-sensor-based-on-cha-reaction-for-egfr-mutation-typing-in-advanced-lung-cancer-45641 https://curecurrent.com/trials/revlimid-capsules-drug-use-results-surveillance-relapsed-or-refractory-atll-45642 https://curecurrent.com/trials/clinical-validation-and-benchmarking-of-top-performing-ctdna-diagnostics-stage-iii-nsclc-45643 https://curecurrent.com/trials/a-study-to-learn-about-the-effectiveness-of-cancer-medicines-in-patients-with-metastatic-non-small-cell-lung-cancer-in-n-45644 https://curecurrent.com/trials/serologic-response-to-the-sars-cov-2-covid-19-mrna-1273-vaccine-in-select-subsets-of-oncology-patients-45645 https://curecurrent.com/trials/evaluation-of-18f-alf-nota-pcp2-pet-ct-for-pd-l1-detection-in-malignant-tumors-45646 https://curecurrent.com/trials/a-study-of-the-safety-and-efficacy-of-pemetrexed-combined-with-nivolumab-via-intraventricular-injection-for-the-treatmen-45647 https://curecurrent.com/trials/combining-afatinib-and-concurrent-chemotherapy-followed-by-osimertinib-and-concurrent-chemotherapy-in-untreated-egfr-pos-45648 https://curecurrent.com/trials/comparing-different-sizes-of-small-bore-chest-drains-in-malignant-pleural-effusion-45649 https://curecurrent.com/trials/chest-lymph-node-sampling-in-patients-with-advanced-lung-cancer-to-be-treated-with-curative-intent-radiation-treatment-45650 https://curecurrent.com/trials/long-term-follow-up-of-checkpoint-inhibitors-induced-ileo-colitis-45651 https://curecurrent.com/trials/a-study-of-rgx-104-in-patients-with-advanced-lung-endometrial-cancer-45652 https://curecurrent.com/trials/identification-of-multiple-pulmonary-diseases-using-volatile-organic-compounds-biomarkers-in-human-exhaled-breath-45653 https://curecurrent.com/trials/cisplatin-cis-administered-as-dry-powder-for-inhalation-dpi-in-patients-with-stage-iv-non-small-cell-lung-cancer-45654 https://curecurrent.com/trials/liquid-biopsy-assay-of-ebus-tbna-supernatant-fluid-for-diagnosing-lung-cancer-45655 https://curecurrent.com/trials/a-study-to-investigate-the-safety-pharmacokinetics-and-clinical-activity-of-ap203-in-patients-with-locally-advanced-or-m-45656 https://curecurrent.com/trials/pulmonary-physiology-and-systemic-inflammatory-in-eo-pulmonary-events-with-brigatinib-use-in-nsclc-and-other-diseases-45657 https://curecurrent.com/trials/explore-the-mechanisms-underlying-disease-resistance-and-potential-primary-resistance-mechanism-of-induction-therapy-lor-45658 https://curecurrent.com/trials/cardiopulmonary-toxicity-of-thoracic-radiotherapy-45659 https://curecurrent.com/trials/a-trial-of-pembrolizumab-in-combination-with-chemotherapy-and-radiotherapy-in-stage-iii-nsclc-keynote-799-mk-3475-799-45660 https://curecurrent.com/trials/a-study-of-bemarituzumab-monotherapy-and-combination-with-other-anti-cancer-therapy-in-sqnsclc-with-fgfr2b-overexpressio-45661 https://curecurrent.com/trials/ono-4538-study-in-patients-with-advanced-non-small-cell-lung-cancer-45662 https://curecurrent.com/trials/evaluation-of-a-scalable-decision-support-and-shared-decision-making-tool-for-lung-cancer-screening-45663